<SEC-DOCUMENT>0001628280-25-015646.txt : 20250331
<SEC-HEADER>0001628280-25-015646.hdr.sgml : 20250331
<ACCEPTANCE-DATETIME>20250331160633
ACCESSION NUMBER:		0001628280-25-015646
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		17
CONFORMED PERIOD OF REPORT:	20250326
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250331
DATE AS OF CHANGE:		20250331

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HUMANA INC
		CENTRAL INDEX KEY:			0000049071
		STANDARD INDUSTRIAL CLASSIFICATION:	HOSPITAL & MEDICAL SERVICE PLANS [6324]
		ORGANIZATION NAME:           	02 Finance
		EIN:				610647538
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-05975
		FILM NUMBER:		25793205

	BUSINESS ADDRESS:	
		STREET 1:		500 W MAIN ST
		CITY:			LOUISVILLE
		STATE:			KY
		ZIP:			40202
		BUSINESS PHONE:		5025801000

	MAIL ADDRESS:	
		STREET 1:		500 W. MAIN ST
		CITY:			LOUISVILLE
		STATE:			KY
		ZIP:			40202

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	EXTENDICARE INC
		DATE OF NAME CHANGE:	19740404

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HERITAGE HOUSE OF AMERICA INC
		DATE OF NAME CHANGE:	19671129
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>hum-20250326.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:b8d6c879-28c4-42c2-9fee-6c511a7e9ff9,g:db6499c3-a5bf-4115-99d2-37d705b81ee5,d:599a116859264c7ebf4eef90a523c402-->
<html xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>hum-20250326</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-21">0000049071</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" id="f-22">false</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="hum-20250326.xsd"/></ix:references><ix:resources><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-03-26</xbrli:startDate><xbrli:endDate>2025-03-26</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i599a116859264c7ebf4eef90a523c402_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Washington, DC 20549</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">8-K</ix:nonNumeric>&#160;</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Pursuant to Section 13 or 15(d) of The</span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Securities Exchange Act of 1934</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Date of Report (Date of earliest event reported): March 31, 2025 (<ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-2">March 26, 2025</ix:nonNumeric>)</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:24pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-3">Humana Inc.</ix:nonNumeric>&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.234%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-4">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-5">001-05975</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-6">61-0647538</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(State or other jurisdiction <br/>of incorporation)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Commission <br/>File Number)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(IRS Employer <br/>Identification No.)</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-7">500 W. Main Street</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-8">Louisville</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="f-9">Kentucky</ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-10">40202</ix:nonNumeric>&#160;</span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Address of principal executive offices, and Zip Code)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-11">502</ix:nonNumeric>-<ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-12">580-1000</ix:nonNumeric>&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Registrant&#8217;s telephone number, including area code</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Former name or former address, if changed since last report)</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">see</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> General Instruction A.2. below):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:2.105%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:95.695%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox" id="f-13">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox" id="f-14">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox" id="f-15">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox" id="f-16">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.457%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.457%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:51.786%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Title of each class</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Trading Symbol(s)</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-17">Common Stock</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-18">HUM</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-19">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="f-20">&#9744;</ix:nonNumeric></span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i599a116859264c7ebf4eef90a523c402_161"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1.01.&#160;&#160;&#160;&#160; Entry into a Material Definitive Agreement.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Underwriting Agreement</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 26, 2025, Humana Inc. (the &#8220;Company&#8221;) entered into an underwriting agreement (the &#8220;Underwriting Agreement&#8221;) with J.P. Morgan Securities LLC and Barclays Capital Inc., as representatives of the several underwriters (together, the &#8220;Underwriters&#8221;), pursuant to which the Company agreed to issue and sell to the Underwriters an additional $250 million aggregate principal amount of its 5.375% Senior Notes due 2031 (the &#8220;Additional 2031 Notes&#8221;), in accordance with the terms and conditions set forth in the Underwriting Agreement. The Additional 2031 Notes are an additional issuance of the 5.375% Senior Notes due 2031 that the Company issued in an aggregate principal amount of $1.25 billion on March 13, 2024 (the &#8220;Existing 2031 Notes&#8221; and, together with the Additional 2031 Notes, the &#8220;Notes&#8221;). The Additional 2031 Notes are fungible with the Existing 2031 Notes and form a single series with the Existing 2031 Notes. The Additional 2031 Notes have terms that are identical to the terms of the Existing 2031 Notes (except for the issuance date and issuance price) and have the same ISIN and CUSIP numbers as the Existing 2031 Notes. The Additional 2031 Notes were sold at a public offering price of 99.941% of the aggregate principal amount thereof, plus accrued interest from October 15, 2024 (the most recent interest payment date) to but excluding the settlement date. Following the completion of the offering, together with the previously issued $1.25 billion in aggregate principal amount of the Existing 2031 Notes, the total outstanding aggregate principal amount of the Notes is $1.5 billion.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The sale of the Additional 2031 Notes has been registered with the Securities and Exchange Commission (the &#8220;Commission&#8221;) in a registration statement on Form S-3, File No. 333-277734 (the &#8220;Registration Statement&#8221;). The terms of the Additional 2031 Notes are described in the Company&#8217;s Prospectus dated March 7, 2024, as supplemented by a final Prospectus Supplement dated March 26, 2025 as filed with the Commission on March 27, 2025, pursuant to Rule 424(b)(5) under the Securities Act of 1933, as amended.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Underwriters and their affiliates have performed commercial banking, investment banking, corporate trust and advisory services for the Company from time to time for which they have received customary fees and expenses. The Underwriters and their affiliates may, from time to time, engage in transactions with and perform services for the Company in the ordinary course of their business. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, certain affiliates of the Underwriters</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> are lenders under the Company&#8217;s revolving credit facility and 364-day credit facility, and the Underwriters or their affiliates may hold the Company&#8217;s existing senior notes for their own accounts.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company estimates that the net proceeds from the sale of the Additional 2031 Notes, after deducting the Underwriters&#8217; discounts and commissions and estimated offering expenses, will be approximately $247 million. The Company intends to use the net proceeds from the Additional 2031 Notes offerings for general corporate purposes, which may include the repayment of existing indebtedness.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A copy of the Underwriting Agreement is filed as Exhibit 1.1 to this Current Report on Form 8-K and is incorporated by reference herein. The description of the material terms of the Underwriting Agreement is qualified in its entirety by reference to such exhibit.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Indenture, Twenty-Eighth Supplemental Indenture</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 31, 2025, the Company completed a public offering of the Additional 2031 Notes. The Additional 2031 Notes are an additional issuance of the Existing 2031 Notes under an indenture dated as of August 5, 2003, by and between the Company and The Bank of New York Mellon Trust Company, N.A. (formerly known as The Bank of New York Trust Company, N.A.) (as successor to The Bank of New York), as trustee (the &#8220;Trustee&#8221;) (the &#8220;Original Indenture&#8221;), as supplemented by the twenty-eighth supplemental indenture, dated as of March 13, 2024, by and between the Company and the Trustee relating to the Notes (the &#8220;Twenty-Eighth Supplemental Indenture&#8221; and, together with the Original Indenture, the &#8220;Indenture&#8221;). </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the terms of the Indenture, the Additional 2031 Notes are unsecured senior obligations of the Company and rank equally with all of the Company&#8217;s other unsecured, unsubordinated indebtedness, including the </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Existing 2031 Notes. The Additional 2031 Notes bear interest at an annual rate of 5.375%. Interest on the Additional 2031 Notes is payable by the Company on April 15 and October 15 of each year, beginning on April 15, 2025. The Additional 2031 Notes mature on April 15, 2031. </span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A copy of the Original Indenture is filed as Exhibit 4.1 to this Current Report on Form 8-K and is incorporated by reference herein. A copy of the Twenty-Eighth Supplemental Indenture is filed as Exhibit 4.2 to this Current Report on Form 8-K and is incorporated by reference herein. The form of 5.375% Senior Notes due 2031 is filed as Exhibit 4.3 to this Current Report on Form 8-K and is incorporated by reference herein. The descriptions of the material terms of the Original Indenture, the Twenty-Eighth Supplemental Indenture and the Additional 2031 Notes are qualified in their entirety by reference to such exhibits. In addition, the legal opinion of Fried, Frank, Harris, Shriver &amp; Jacobson LLP related to the Additional 2031 Notes is filed as Exhibit 5.1 to this Current Report on Form 8-K and is incorporated herein by reference.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Trustee has also been appointed registrar and paying agent with regard to the Additional 2031 Notes and serves the same roles with respect to certain other series of the Company&#8217;s outstanding senior notes. An affiliate of the Trustee is also a lender under the Company&#8217;s revolving credit facility and 364-day credit facility.</span></div><div id="i599a116859264c7ebf4eef90a523c402_185"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.03.&#160;&#160;&#160;&#160; Creation of a Direct Financial Obligation or an Obligation Under an Off-Balance Sheet Arrangement of a Registrant.</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by Item 2.03 contained under the heading &#8220;Indenture, Twenty-Eighth Supplemental Indenture&#8221; in Item 1.01 of this Current Report on Form 8-K is incorporated herein by reference.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i599a116859264c7ebf4eef90a523c402_209"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="-sec-extract:summary;margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9.01.&#160;&#160;&#160;&#160;Financial Statements and Exhibits.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) Exhibits:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:8.515%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:88.644%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.15pt;padding-left:0.02pt;padding-right:0.02pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit No.</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1.01pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit11-8xk.htm">Underwriting Agreement, dated </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit11-8xk.htm">March </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit11-8xk.htm">26, 2025, among the Company and J.P. Morgan Securities LLC and Barclays Capital Inc., as representatives of the several underwriters.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;margin-top:2.15pt;padding-left:0.02pt;padding-right:0.02pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/49071/000119312503073141/dex41.htm">Indenture, dated as of August 5, 2003, by and between the Company and The Bank of New York, as trustee (incorporated herein by reference to Exhibit 4.1 to Humana Inc.&#8217;s Quarterly Report on Form 10-Q for the quarter ended September 30, 2003).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;margin-top:2.15pt;padding-left:0.02pt;padding-right:0.02pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/49071/000162828024010997/exhibit42-8xk31224.htm">Twenty-Eighth Supplemental Indenture, dated March 13, 2024, between the Company and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated herein by reference to Exhibit 4.</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/49071/000162828024010997/exhibit42-8xk31224.htm">2</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/49071/000162828024010997/exhibit42-8xk31224.htm"> to Humana Inc.&#8217;s Current Report on Form 8-K filed on March 13, 2024).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;margin-top:2.15pt;padding-left:0.02pt;padding-right:0.02pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/49071/000162828024010997/exhibit43-8xk31224.htm">Form of 5.375% Senior Notes due 2031 (incorporated herein by reference to Exhibit 4.3 to Humana Inc.&#8217;s Current Report on Form 8-K filed on March 13, 2024).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit51-8xk.htm">Opinion of Fried, Frank, Harris, Shriver &amp; Jacobson LLP.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit51-8xk.htm">Consent of Fried, Frank, Harris, Shriver &amp; Jacobson LLP (included in</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit51-8xk.htm"> Exhibit 5.1).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1.02pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (embedded within the Inline XBRL document).</span></td></tr></table></div><div><span><br/></span></div><div id="i599a116859264c7ebf4eef90a523c402_232"></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-bottom:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div style="padding-left:166.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:64.423%"><tr><td style="width:1.0%"/><td style="width:7.108%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:90.692%"/><td style="width:0.1%"/></tr><tr><td colspan="6" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">HUMANA INC.</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">BY:</span></td><td colspan="3" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ John-Paul W. Felter</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">John-Paul W. Felter</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Senior Vice President, Chief Accounting Officer and Controller</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Principal Accounting Officer)</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dated: March 31, 2025</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>exhibit11-8xk.htm
<DESCRIPTION>EX-1.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i6a0bf2464f934039a01e08067fe5ed83_77"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 1.1</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Execution Version</font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:113%"> </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:113%">$250,000,000</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:113%">HUMANA INC.</font></div><div style="margin-bottom:24pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:113%">$250,000,000 5.375% Senior Notes due 2031</font></div><div style="margin-bottom:24pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:113%;text-decoration:underline">UNDERWRITING AGREEMENT</font></div><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">March 26, 2025</font></div><div style="padding-left:76.5pt;text-indent:-76.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">J.P. MORGAN SECURITIES LLC</font></div><div style="padding-left:76.5pt;text-indent:-76.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">BARCLAYS CAPITAL INC.</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">As Representatives of the several</font></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">Underwriters named in Schedule 1</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">c&#47;o J.P. Morgan Securities LLC</font></div><div style="padding-right:-87.9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">383 Madison Avenue</font></div><div style="margin-bottom:12pt;padding-left:76.5pt;text-indent:-76.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">New York, New York 10179</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">Barclays Capital Inc.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">745 Seventh Avenue</font></div><div style="margin-bottom:24pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">New York, NY 10019 </font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">Dear Ladies and Gentlemen&#58; </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">Humana Inc., a Delaware corporation (the &#8220;Company&#8221;), proposes to sell $250,000,000</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:113%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">aggregate principal amount of the Company&#8217;s 5.375% Senior Notes due 2031 (the &#8220;Additional Notes&#8221;). The Additional Notes offered hereby will be an additional issuance of the 5.375% Senior Notes due 2031 that were issued in an aggregate principal amount of $1,250,000,000 on March 13, 2024 (referred to herein as the &#8220;Existing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:113%;position:relative;top:-4.2pt;vertical-align:baseline"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">2031 Notes&#8221; and, where the context requires, together with the Additional Notes, referred to herein as the &#8220;Notes&#8221;). The Additional Notes are to be issued pursuant to an Indenture, dated as of August 5, 2003 (the &#8220;Base Indenture&#8221;), as supplemented by the Twenty-Eighth Supplemental Indenture, dated as of March 13, 2024 (the &#8220;2031 Notes Supplemental Indenture&#8221;&#59; the Base Indenture, as supplemented by the 2031 Notes Supplemental Indenture, the &#8220;Indenture&#8221;), between the Company and The Bank of New York Mellon Trust Company, N.A. (formerly known as The Bank of New York Trust Company, N.A.) (as successor to The Bank of New York)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:113%">,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%"> as trustee (the &#8220;Trustee&#8221;). This is to confirm the agreement concerning the purchase of the Additional Notes from the Company by the Underwriters named in Schedule 1 hereto (the &#8220;Underwriters&#8221;).</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2</font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:113%">Representations, Warranties and Agreements of the Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">.  The Company represents, warrants and agrees that&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">(a)&#160;&#160;&#160;&#160;A registration statement on Form S-3 with respect to the Additional Notes has (i) been prepared by the Company in conformity with the requirements of the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), and the rules and regulations (the &#8220;Rules and Regulations&#8221;) of the Securities and Exchange Commission (the &#8220;Commission&#8221;) thereunder, (ii) been filed with the Commission under the Securities Act and (iii) become effective under the Securities Act&#59; and the Base Indenture has been qualified under the Trust Indenture Act of 1939, as amended (the &#8220;Trust Indenture Act&#8221;).  Copies of such registration statement and any amendments thereto have been delivered by the Company to you as the Representatives (the &#8220;Representatives&#8221;) of the Underwriters.  The Company has also filed, or proposes to file, with the Commission pursuant to Rule 424 under the Securities Act a prospectus supplement specifically relating to the Additional Notes (the &#8220;Prospectus Supplement&#8221;).  As used in this Agreement, &#8220;Effective Time&#8221; means the date and the time as of which any part of such registration statement became, or is deemed to have become, effective under the Securities Act in accordance with the Rules and Regulations&#59; &#8220;Effective Date&#8221; means the date of any Effective Time&#59; &#8220;Issuer Free Writing Prospectus&#8221; means each &#8220;free writing prospectus&#8221; (as defined in Rule 405 of the Rules and Regulations) prepared by or on behalf of the Company or used or referred to by the Company in connection with the offering of the Additional Notes&#59; &#8220;Preliminary Prospectus&#8221; means each preliminary prospectus included in such registration statement, or amendments thereof, or filed with the Commission by the Company with the consent of the Representatives, as provided herein, pursuant to Rule 424(b) of the Rules and Regulations and the preliminary prospectus supplement specifically relating to the Additional Notes&#59; &#8220;Registration Statement&#8221; means such registration statement, as amended at the most recent Effective Time, including any documents incorporated by reference therein at such time and all information contained in the final Prospectus filed with the Commission pursuant to Rule 424(b) of the Rules and Regulations in accordance with Section 5(a) hereof and deemed to be a part of the registration statement as of such Effective Time pursuant to Rule 430A, Rule 430B or Rule 430C of the Rules and Regulations&#59; &#8220;Prospectus&#8221; means such final prospectus as supplemented by the Prospectus Supplement specifically relating to the Additional Notes in the form first used to confirm sales of the Additional Notes and as filed with the Commission pursuant to Rule 424(b) of the Rules and Regulations&#59; &#8220;Time of Sale&#8221; means the time when sales or contracts for sales of the Additional Notes were first made&#59; and &#8220;Pricing Disclosure Package&#8221; means, as of the Time of Sale, the most recent Preliminary Prospectus, together with each Issuer Free Writing Prospectus listed on Schedule 2(A) hereto.  Reference made herein to any Preliminary Prospectus or to the Prospectus shall be deemed to refer to and include any documents incorporated by reference therein pursuant to Item 12 of Form S-3 under the Securities Act, as of the date of such Preliminary Prospectus or the Prospectus, as the case may be, and any reference to any amendment or supplement to any Preliminary Prospectus or the Prospectus shall be deemed to refer to and include any document filed under the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), after the date of such Preliminary Prospectus or the Prospectus, as the case may be, and incorporated by reference in such Preliminary Prospectus or the Prospectus, as the case may be&#59; and any reference to any amendment to the Registration Statement shall be deemed to include any </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3</font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">annual report of the Company filed with the Commission pursuant to Section 13(a) or 15(d) of the Exchange Act after the initial Effective Time that is incorporated by reference in the Registration Statement.  The Commission has not issued any order preventing or suspending the use of any Preliminary Prospectus or the Prospectus or suspending the effectiveness of the Registration Statement, and no proceeding or examination for such purpose has, to the knowledge of the Company, been instituted or threatened by the Commission.  The Commission has not notified the Company of any objection to the use of the form of the Registration Statement pursuant to Rule 401(g)(2) of the Rules and Regulations.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">(b)&#160;&#160;&#160;&#160;The Company has at all times since the time of the initial filing of the Registration Statement been and continues to be a &#8220;well-known seasoned issuer&#8221; (as defined in Rule 405 of the Rules and Regulations) eligible to use Form S-3 for the offering of the Additional Notes, including not having been an &#8220;ineligible issuer&#8221; (as defined in Rule 405 of the Rules and Regulations) at any time since such time, and is not the subject of a pending proceeding under Section 8A of the Securities Act.  The Registration Statement is an &#8220;automatic shelf registration statement&#8221; (as defined in Rule 405 of the Rules and Regulations) and was filed not earlier than the date that is three years prior to the Delivery Date (as defined in Section 4 hereof).  The conditions for use of Form S-3, as set forth in the General Instructions thereto, have been satisfied.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">(c)&#160;&#160;&#160;&#160;The Registration Statement conformed and will conform in all material respects on each applicable Effective Date and on the Delivery Date, and any amendment to the Registration Statement filed after the date hereof will conform in all material respects when filed, to the requirements of the Securities Act and the Rules and Regulations.  The Preliminary Prospectus conformed, and the Prospectus will conform, in all material respects when filed with the Commission pursuant to Rule 424(b) and on the Delivery Date to the requirements of the Securities Act and the Rules and Regulations.  The documents incorporated by reference into the Pricing Disclosure Package or the Prospectus conformed, and any further documents so incorporated will conform, when filed with the Commission, in all material respects to the requirements of the Exchange Act or the Securities Act, as applicable, and the rules and regulations of the Commission thereunder.  The Indenture conforms in all material respects to the requirements of the Trust Indenture Act and the applicable rules and regulations thereunder.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">(d)&#160;&#160;&#160;&#160;The Registration Statement did not, as of each applicable Effective Date, contain an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading&#59; provided that no representation or warranty is made as to information contained in or omitted from the Registration Statement in reliance upon and in conformity with the Underwriters&#8217; Information (as defined in Section 8(e) hereof).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">(e)&#160;&#160;&#160;&#160;The Prospectus will not, as of its date, the date of any amendment or supplement thereto or the Delivery Date, contain an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading&#59; provided that no representation or warranty is made as to information contained in or </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4</font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">omitted from the Prospectus in reliance upon and in conformity with the Underwriters&#8217; Information.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">(f)&#160;&#160;&#160;&#160;The documents incorporated by reference in the Registration Statement, the Pricing Disclosure Package or the Prospectus did not, and any further documents filed and incorporated by reference therein will not, when filed with the Commission, contain an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">(g)&#160;&#160;&#160;&#160;The Pricing Disclosure Package as of the Time of Sale did not, and at the Delivery Date will not, contain an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading&#59; provided that no representation or warranty is made as to information contained in or omitted from the Pricing Disclosure Package in reliance upon and in conformity with the Underwriters&#8217; Information.  No statement of material fact included in the Prospectus has been omitted from the Pricing Disclosure Package, and no statement of material fact included in the Pricing Disclosure Package that is required to be included in the Prospectus has been omitted therefrom.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">(h)&#160;&#160;&#160;&#160;Each Issuer Free Writing Prospectus conformed or will conform in all material respects to the requirements of the Securities Act and the Rules and Regulations on the date of first use, and the Company has complied with any filing requirements applicable to such Issuer Free Writing Prospectus pursuant to the Rules and Regulations.  No Issuer Free Writing Prospectus includes any information that conflicts with the information contained in the Registration Statement, including any document incorporated therein and any prospectus supplement deemed to be a part thereof that has not been superseded or modified.  The Company has retained in accordance with the Rules and Regulations all Issuer Free Writing Prospectuses that were not required to be filed pursuant to the Rules and Regulations. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">(i)&#160;&#160;&#160;&#160;The Company has not distributed and, prior to the completion of the delivery of the Additional Notes, will not distribute, any offering material in connection with the offering and sale of the Additional Notes other than any Preliminary Prospectus, the Prospectus and any Issuer Free Writing Prospectus set forth on Schedule 2 hereto.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">(j)&#160;&#160;&#160;&#160;(i) The Company has been duly incorporated and is validly existing as a corporation in good standing under the laws of the State of Delaware, (ii) each of the Company&#8217;s subsidiaries (as defined in Section 16 hereof) has been duly organized and is validly existing and in good standing under the laws of its respective jurisdiction of organization, and (iii) except as would not result in a material adverse effect on the business, properties, results of operations or financial condition of the Company and its subsidiaries, taken as a whole (a &#8220;Material Adverse Effect&#8221;), the Company and each of its subsidiaries are duly qualified to do business and are in good standing in each jurisdiction in which their respective ownership or lease of property or the conduct of their respective businesses requires such qualification.  The Company and each of its subsidiaries have all </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5</font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">power and authority necessary to own or hold their respective properties and to conduct the businesses in which they are engaged, and none of the subsidiaries of the Company is a &#8220;significant subsidiary&#8221; (as such term is defined in Rule 405 of the Rules and Regulations) except for CenterWell Health Services, Inc., Conviva Group Holdings, LLC,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:113%;position:relative;top:-4.2pt;vertical-align:baseline"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">Humana Insurance Company, Humana Medical Plan, Inc. and Metropolitan Health Networks, Inc. (together, the &#8220;Significant Subsidiaries&#8221;).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">(k)&#160;&#160;&#160;&#160;The Company has an authorized capitalization as set forth in the Preliminary Prospectus and the Prospectus in the column entitled &#8220;Actual&#8221; under the caption &#8220;Capitalization&#8221;, and all of the issued shares of capital stock of the Company have been duly and validly authorized and issued, are fully paid and non-assessable and conform in all material respects to the description thereof contained in the Annual Report on Form 10-K for the fiscal year ended December 31, 2024&#59; and all of the issued shares of capital stock or other equity interest of each subsidiary of the Company have been duly and validly authorized and issued and are fully paid and non-assessable and (except for directors&#8217; qualifying shares or as set forth on Schedule 3 hereto) are owned directly or indirectly by the Company, free and clear of all liens, encumbrances, equities or claims.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">(l)&#160;&#160;&#160;&#160;The Company has all requisite power and authority to execute, deliver and perform its obligations under the Indenture and the Additional Notes&#59; and the Indenture has been duly authorized, executed and delivered by the Company, and constitutes a valid and binding agreement of the Company enforceable against the Company in accordance with its terms, subject to the effects of bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium and other similar laws relating to or affecting creditors&#8217; rights generally, general equitable principles (whether considered in a proceeding in equity or at law) or an implied covenant of good faith and fair dealing&#59; and the Additional Notes have been duly authorized, and, when duly executed, authenticated, issued and delivered as provided in the Indenture, will be duly and validly issued and outstanding, and will constitute valid and binding obligations of the Company entitled to the benefits of the Indenture and enforceable in accordance with their terms, subject to the effects of bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium and other similar laws relating to or affecting creditors&#8217; rights generally, general equitable principles (whether considered in a proceeding in equity or at law) or an implied covenant of good faith and fair dealing&#59; and the Additional Notes, when issued and delivered, will conform to the descriptions thereof contained in the Pricing Disclosure Package and the Prospectus in all material respects.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">(m)&#160;&#160;&#160;&#160;The Company has all requisite corporate power and authority to enter into this Agreement&#59; and this Agreement has been duly authorized, executed and delivered by the Company.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">(n)&#160;&#160;&#160;&#160;The execution, delivery and performance of this Agreement and the Indenture by the Company and the consummation of the transactions contemplated hereby and thereby, and the issuance and delivery of the Additional Notes will not conflict with or result in a breach or violation of any of the terms or provisions of, or constitute a default under, any indenture, mortgage, deed of trust, loan agreement, agreement with any governmental or regulatory authority to which the Company or any of its Significant </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6</font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">Subsidiaries is a party or by which the Company or any of its Significant Subsidiaries is bound or to which any of the property or assets of the Company or its Significant Subsidiaries is subject, or any other material agreement or instrument to which the Company or any of its subsidiaries is a party or by which the Company or any of its subsidiaries is bound or to which any of the property or assets of the Company or any of its subsidiaries is subject, nor will such actions result in any violation of the provisions of (i) the charter or by-laws (or other similar organizational documents) of the Company or any of its subsidiaries or (ii) any statute or any order, rule or regulation of any governmental agency or body or court having jurisdiction over the Company or any of its subsidiaries or any of their properties or assets, except, in the case of clause (ii), such violations as would not have a Material Adverse Effect&#59; and except for the registration of the Additional Notes under the Securities Act and such consents, approvals, authorizations, registrations or qualifications as may be required under the Trust Indenture Act and applicable foreign or state securities or blue sky laws in connection with the purchase and distribution of the Additional Notes by the Underwriters, no consent, approval, authorization or order of, or filing or registration with, any such governmental agency or body or court is required for the execution, delivery and performance of this Agreement or the Indenture by the Company and the consummation of the transactions contemplated hereby and thereby and the issuance and sale of the Additional Notes.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">(o)&#160;&#160;&#160;&#160;There are no contracts, agreements or understandings between the Company and any person granting such person the right to require the Company to include any securities other than the Additional Notes in the securities registered pursuant to the Registration Statement.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">(p)&#160;&#160;&#160;&#160;Neither the Company nor any of its subsidiaries has sustained, since the date of the latest audited financial statements included or incorporated by reference in the Preliminary Prospectus and the Prospectus, any material loss or interference with its business from fire, explosion, flood or other calamity, whether or not covered by insurance, or from any labor dispute or court or governmental action, order or decree, otherwise than as set forth in the Pricing Disclosure Package and the Prospectus&#59; and, since such date, there has not been any change in the capital stock or long-term debt of the Company or any of its subsidiaries or any Material Adverse Effect, otherwise than as set forth in the Pricing Disclosure Package and the Prospectus.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">(q)&#160;&#160;&#160;&#160;The financial statements (including the related notes and any supporting schedules) filed as part of the Registration Statement or included or incorporated by reference in the Pricing Disclosure Package and the Prospectus present fairly the financial condition and results of operations of the entities purported to be shown thereby, at the dates and for the periods indicated, and have been prepared in conformity with generally accepted accounting principles in the United States applied on a consistent basis throughout the periods involved. The interactive data in eXtensible Business Reporting Language included or incorporated by reference in the Registration Statement, the Pricing Disclosure Package and the Prospectus fairly presents the information called for in all material respects and is prepared in accordance with the Commission&#8217;s rules and guidelines applicable thereto. No pro forma financial information is required to be filed with the Commission </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7</font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">pursuant to Regulation S-X with respect to any acquisitions or dispositions by the Company since January 1, 2024.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">(r)&#160;&#160;&#160;&#160;PricewaterhouseCoopers LLP, who have certified certain financial statements of the Company, whose report is incorporated by reference in the Registration Statement, the Preliminary Prospectus and the Prospectus and who have delivered the initial letter referred to in Section 7(g) hereof, is an independent registered public accounting firm with respect to the Company within the applicable rules and regulations adopted by the Commission and the Public Company Accounting Oversight Board (United States) and as required by the Securities Act and the Rules and Regulations during the periods covered by the financial statements on which it reported and which are contained or incorporated in the Registration Statement, the Preliminary Prospectus and the Prospectus.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">(s)&#160;&#160;&#160;&#160;The Company and each of its subsidiaries have good and marketable title in fee simple to all real property and good and valid title to all personal property owned by them, in each case free and clear of all liens, encumbrances and defects except such as are described in the Pricing Disclosure Package and the Prospectus or such as do not materially affect the value of such property and do not materially interfere with the use made and proposed to be made of such property by the Company and its subsidiaries&#59; and all real property and buildings held under lease by the Company and its subsidiaries are held by them under valid, subsisting and enforceable leases, with such exceptions as are not material and do not interfere with the use made and proposed to be made of such property and buildings by the Company and its subsidiaries.  </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">(t)&#160;&#160;&#160;&#160;The Company and each of its subsidiaries carry, or are covered by, insurance in such amounts and covering such risks as is adequate for the conduct of their respective businesses and the value of their respective properties and as is customary for companies engaged in similar businesses in similar industries.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">(u)&#160;&#160;&#160;&#160;The Company and each of its subsidiaries own or possess adequate rights to use all material patents, patent applications, trademarks, service marks, trade names, trademark registrations, service mark registrations, copyrights and licenses necessary for the conduct of their respective businesses and have no reason to believe that the conduct of their respective businesses will conflict with, and have not received any notice of any claim of conflict with, any such rights of others, except for such claims as would not have a Material Adverse Effect.  </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">(v)&#160;&#160;&#160;&#160;Other than as expressly set forth in the Pricing Disclosure Package and the Prospectus, there are no legal or governmental proceedings pending to which the Company or any of its subsidiaries is a party or of which any property or assets of the Company or any of its subsidiaries is the subject which, if determined adversely to the Company or any of its subsidiaries, could reasonably be expected to have a Material Adverse Effect&#59; and to the Company&#8217;s knowledge, no such proceedings are threatened or contemplated by governmental authorities or threatened by others. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8</font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:111%">(w)&#160;&#160;&#160;&#160;There are no contracts or other documents which are required to be described in the Preliminary Prospectus and the Prospectus or filed as exhibits to the Registration Statement by the Securities Act or by the Rules and Regulations which have not been described in the Preliminary Prospectus and the Prospectus or filed as exhibits to the Registration Statement or incorporated therein by reference as permitted by the Rules and Regulations.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:111%">(x)&#160;&#160;&#160;&#160;No relationship, direct or indirect, exists between or among the Company or any of its subsidiaries, on the one hand, and the directors, officers, stockholders, customers or suppliers of the Company or any of its subsidiaries, on the other hand, that is required to be described or incorporated by reference in the Preliminary Prospectus and the Prospectus which is not so described or incorporated by reference.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:111%">(y)&#160;&#160;&#160;&#160;No labor disturbance by the employees of the Company exists or, to the knowledge of the Company, is imminent which might be expected to have a Material Adverse Effect.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:111%">(z)&#160;&#160;&#160;&#160;The Company and each of its subsidiaries are in compliance with all applicable federal and state statutes, regulations, rules and orders relating to the healthcare and insurance industries, in each case with such exceptions as would not have a Material Adverse Effect.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:111%">(aa)&#160;&#160;&#160;&#160;There has been no, and the Company and its subsidiaries have not been notified of and have no knowledge of any, event or condition that would reasonably be expected to result in an information security breach or other compromise of any of the Company&#8217;s or any of its subsidiaries&#8217; information technology and computer systems, networks, hardware, software, data, equipment or technology (including the foregoing of their respective customers, employees, suppliers and vendors with respect to the Company and its subsidiaries&#8217; businesses) (collectively, &#8220;IT Systems and Data&#8221;), where such security breach or compromise has had or would have, individually or in the aggregate, a Material Adverse Effect. The Company and its subsidiaries (i) are presently in compliance with all applicable laws or statutes and all judgments, orders, rules and regulations of any court, arbitrator or governmental or regulatory authority, internal policies and contractual obligations, in each case, relating to the privacy and security of IT Systems and Data, and to the protection of such IT Systems and Data from unauthorized use, access, misappropriation or modification, except for any non-compliance that would not, individually or in the aggregate, have a Material Adverse Effect&#59; and (ii) have implemented backup and disaster recovery technology consistent with industry standards and practices.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:111%">(bb)&#160;&#160;&#160;&#160;The Company is in compliance in all material respects with all applicable provisions of the Employee Retirement Income Security Act of 1974, as amended, including the regulations and published interpretations thereunder (&#8220;ERISA&#8221;)&#59; to the best of the Company&#8217;s knowledge no &#8220;reportable event&#8221; (as defined in ERISA) has occurred with respect to any &#8220;pension plan&#8221; (as defined in ERISA) for which the Company would have any material liability&#59; to the best of the Company&#8217;s knowledge the Company has not incurred and does not expect to incur any material liability under (i) Title IV of ERISA with respect to termination of, or withdrawal from, any &#8220;pension plan&#8221; or (ii) Sections 412 </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">9</font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">or 4971 of the Internal Revenue Code of 1986, as amended, including the regulations and published interpretations thereunder (the &#8220;Code&#8221;)&#59; and each &#8220;pension plan&#8221; for which the Company would have any liability that is intended to be qualified under Section 401(a) of the Code is so qualified in all material respects and to the best of the Company&#8217;s knowledge nothing has occurred, whether by action or by failure to act, which would cause the loss of such qualification.  </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">(cc)&#160;&#160;&#160;&#160;Except as would not have a Material Adverse Effect, the Company has filed all federal, state, local and foreign tax returns required to be filed through the date hereof and has paid all taxes due thereon. No tax deficiency has been determined adversely to the Company or any of its subsidiaries which has had (nor does the Company have any knowledge of any tax deficiency which, if determined adversely to the Company or any of its subsidiaries, might have) a Material Adverse Effect.  </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">(dd)&#160;&#160;&#160;&#160;Since the date as of which information is given in the Pricing Disclosure Package through the date hereof, and except as may otherwise be disclosed in the Pricing Disclosure Package, the Company has not (i) issued or granted any securities except for employee stock options and restricted stock awards, (ii) incurred any liability or obligation, direct or contingent, other than liabilities and obligations which were incurred in the ordinary course of business, (iii) entered into any transaction not in the ordinary course of business or (iv) declared or paid any dividend on its capital stock.  </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">(ee)&#160;&#160;&#160;&#160;None of the Company or any of its subsidiaries (i) is in violation of its charter or by-laws (or other similar organizational documents), (ii) is in default in any respect, and to the best of the Company&#8217;s knowledge, no event has occurred which, with notice or lapse of time or both, would constitute such a default, in the due performance or observance of any term, covenant or condition contained in any indenture, mortgage, deed of trust, loan agreement or other agreement or instrument to which it is a party or by which it is bound or to which any of its properties or assets is subject or (iii) is in violation in any respect of any law, ordinance, governmental rule, regulation or court decree to which it or its property or assets may be subject or has failed to obtain any license, permit, certificate, franchise or other governmental authorization or permit necessary to the ownership of its property or to the conduct of its business except, with respect to clauses (ii) and (iii), such defaults or violations as would not have a Material Adverse Effect.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">(ff)&#160;&#160;&#160;&#160;The Company and each of its subsidiaries (i) make and keep accurate books and records and (ii) maintain internal accounting controls which provide reasonable assurance that (A) transactions are executed in accordance with management&#8217;s authorization, (B) transactions are recorded as necessary to permit preparation of their respective financial statements in conformity with generally accepted accounting principles in the United States and to maintain accountability for its assets, (C) access to its assets is permitted only in accordance with management&#8217;s authorization and (D) the reported accountability for their respective assets is compared with existing assets at reasonable intervals.  </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">(gg)&#160;&#160;&#160;&#160;The Company and each of its subsidiaries are in compliance with all applicable federal and state statutes, regulations, rules and orders relating to the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">10</font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">environmental protection or the protection of human health, in each case with such exceptions as would not have a Material Adverse Effect.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">(hh)&#160;&#160;&#160;&#160;None of the Company or any of its subsidiaries is an &#8220;investment company&#8221; (as such term is used under the Investment Company Act of 1940, as amended (the &#8220;Investment Company Act&#8221;), and the rules and regulations of the Commission thereunder).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">(ii)&#160;&#160;&#160;&#160;The Company, each of its directors and officers (as it relates to the Company) and its subsidiaries are in compliance with the applicable provisions of the Sarbanes-Oxley Act of 2002 and the rules and regulations of the Commission adopted pursuant thereto, including the provisions of Section 404 thereof, in each case with such exceptions as would not have a Material Adverse Effect.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">(jj)&#160;&#160;&#160;&#160;No forward-looking statement (within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act) contained in the Pricing Disclosure Package or the Prospectus has been made or reaffirmed without a reasonable basis or has been disclosed other than in good faith.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">(kk)&#160;&#160;&#160;&#160;None of the Company, any of its subsidiaries or, to the Company&#8217;s knowledge, any director, officer, agent, employee or affiliate of the Company or any of its subsidiaries (acting on behalf of the Company or any of its subsidiaries, as applicable) (i) has used any funds for any unlawful contribution, gift, entertainment or other unlawful expense relating to political activity&#59; (ii) has made or taken an act in furtherance of an offer, promise or authorization of any direct or indirect unlawful payment or benefit to any foreign or domestic government or regulatory official or employee, including of any government-owned or controlled entity or of a public international organization, or any person acting in an official capacity for or on behalf of any of the foregoing, or any political party or party official or candidate for political office&#59; (iii) is aware of or has taken any action, directly or indirectly, that would result in a violation by such persons of either (x) the Foreign Corrupt Practices Act of 1977, as amended, and the rules and regulations thereunder (the &#8220;FCPA&#8221;), including, without limitation, making use of the mails or any means or instrumentality of interstate commerce corruptly in furtherance of an offer, payment, promise to pay or authorization of the payment of any money, or other property, gift, promise to give, or authorization of the giving of anything of value to any &#8220;foreign official&#8221; (as such term is defined in the FCPA) or any foreign political party or official thereof or any candidate for foreign political office, in contravention of the FCPA or (y) the U.K. Bribery Act 2010 (the &#8220;Bribery Act&#8221;), and the Company, its subsidiaries and, to the Company&#8217;s knowledge, the Company&#8217;s affiliates have conducted their businesses in compliance with the FCPA and the Bribery Act and have instituted and maintain policies and procedures designed to ensure, and which are reasonably expected to continue to ensure, continued compliance therewith or (iv) has made, offered, agreed, requested or taken an act in furtherance of any unlawful bribe or other unlawful benefit, including, without limitation, any rebate, payoff, influence payment, kickback or other unlawful or improper payment or benefit.  </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">(ll)&#160;&#160;&#160;&#160;The operations of the Company and its subsidiaries are and have been conducted at all times in compliance in all material respects with applicable financial </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">11</font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">recordkeeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended, the money laundering statutes of all applicable jurisdictions, the rules and regulations thereunder and any related or similar rules, regulations or guidelines issued, administered or enforced by any governmental agency (collectively, the &#8220;Money Laundering Laws&#8221;) and no action, suit or proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company or any of its subsidiaries, with respect to the Money Laundering Laws is pending or, to the Company&#8217;s knowledge, threatened.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">(mm)&#160;&#160;&#160;&#160;None of the Company, any of its subsidiaries or, to the Company&#8217;s knowledge, any director, officer, agent, employee, affiliate or  representative of the Company, any of its subsidiaries (acting on behalf of the Company or any of its subsidiaries, as applicable) is an individual or entity (&#8220;Person&#8221;) currently the subject or target of any sanctions administered or enforced by the United States Government, including, without limitation, the U.S. Department of the Treasury&#8217;s Office of Foreign Assets Control (&#8220;OFAC&#8221;), or other relevant sanctions authority (collectively, &#8220;Sanctions&#8221;), nor is the Company or any of its subsidiaries, located, organized or resident in a country or territory that is the subject of Sanctions&#59; and the Company will not directly or indirectly use the proceeds of the sale of the Additional Notes, or lend, contribute or otherwise make available such proceeds to any subsidiaries, joint venture partners or other Person, to fund any activities of or business with any Person, or in any country or territory, that, at the time of such funding, is the subject of  Sanctions or in any other manner that will result in a violation by any Person (including any Person participating in the transaction, whether as underwriter, advisor, investor or otherwise) of Sanctions.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">For purposes of this Section 1 as well as for Section 7 hereof, references to &#8220;the Preliminary Prospectus and the Prospectus&#8221; or to &#8220;the Pricing Disclosure Package and the Prospectus&#8221; are to each of such prospectuses (or, in the case of the Pricing Disclosure Package, the Preliminary Prospectus included therein) as a separate or stand-alone document (and not the two such prospectuses taken together).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">2.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:113%">Purchase of the Additional Notes by the Underwriters.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">On the basis of the representations and warranties contained in, and subject to the terms and conditions of, this Agreement, the Company agrees to issue and sell to the several Underwriters and each of the Underwriters, severally and not jointly, agrees to purchase from the Company, at a purchase price of 99.341% of the principal amount thereof, plus accrued interest from October 15, 2024, the respective amount of the $250,000,000 aggregate principal amount of the Additional Notes set forth opposite that Underwriter&#8217;s name in Schedule 1 hereto.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">The Company shall not be obligated to deliver any of the Additional Notes to be delivered on the Delivery Date, except upon payment for all the Additional Notes to be purchased on the Delivery Date as provided herein.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">3.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:113%">Offering of the Additional Notes by the Underwriters.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">Upon authorization by the Representatives of the release of the Additional Notes, the several Underwriters propose to offer the Additional Notes for sale upon the terms and conditions set forth in the Pricing Disclosure Package and Prospectus. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">12</font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:111%">The Company hereby acknowledges that (a) the purchase and sale of the Additional Notes pursuant to this Agreement is an arm&#8217;s-length commercial transaction between the Company, on the one hand, and each Underwriter and any affiliate through which it may be acting, on the other, (b) the Underwriters are acting as principal and not as an agent or fiduciary of the Company and (c) the Company&#8217;s engagement of the Underwriters in connection with</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:111%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:111%">the offering and the process leading up to the offering is as independent contractors and not in any other capacity.  Furthermore, the Company agrees that it is solely responsible for making its own judgments in connection with the offering (irrespective of whether any of the Underwriters has advised or is currently advising the Company on related or other matters).  The Company agrees that it will not claim that the Underwriters have rendered advisory services of any nature or respect, or owe an agency, fiduciary or similar duty to the Company, in connection with such transaction or the process leading thereto.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:111%">4.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:111%">Delivery of and Payment for the Additional Notes.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:111%">  Delivery of and payment for the Additional Notes shall be made at the office of Simpson Thacher &#38; Bartlett LLP, at 10&#58;00 A.M., New York City time, on March 31, 2025 or at such other date or place as shall be determined by agreement between the Representatives and the Company.  This date and time are sometimes referred to as the &#8220;Delivery Date.&#8221;  On the Delivery Date, the Company shall deliver or cause to be delivered the Additional Notes evidenced by one or more global securities registered in the name of Cede &#38; Co. as nominee of The Depository Trust Company (&#8220;DTC&#8221;) for the account of the Underwriters against payment to or upon the order of the Company of the purchase price by wire transfer in immediately available funds.  Time shall be of the essence, and delivery at the time and place specified pursuant to this Agreement is a further condition of the obligation of each Underwriter hereunder.  The Company shall make the Additional Notes available for inspection, either in person or by email, by the Representatives in New York, New York, not later than 5&#58;00 P.M., New York City time, on the business day prior to the Delivery Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:111%">5.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:111%">Further Agreements of the Company.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:111%">  The Company agrees&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:111%">(a)&#160;&#160;&#160;&#160;To prepare the Prospectus in a form approved by the Representatives and to file such Prospectus pursuant to Rule 424(b) under the Securities Act not later than the Commission&#8217;s close of business on the second business day following the execution and delivery of this Agreement or, if applicable, such earlier time as may be required by Rule 430A, Rule 430B or Rule 430C of the Rules and Regulations&#59; to pay to the Commission the registration fees for the offering of the Additional Notes within the time period required by Rule 456(b)(1)(i) of the Rules and Regulations, and in any event no later than one day prior to the Delivery Date, and otherwise in accordance with Rule 456(b) and Rule 457(r) of the Rules and Regulations&#59; to make no further amendment or any supplement to the Registration Statement or to the Prospectus prior to the Delivery Date except as permitted herein&#59; to advise the Representatives, promptly after it receives notice thereof, of the time when any amendment to the Registration Statement has been filed or becomes effective or any supplement to the Prospectus or any amended Prospectus has been filed and to furnish the Representatives with copies thereof&#59; to file promptly all reports and any definitive proxy or information statements required to be filed by the Company with the Commission pursuant to Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act subsequent to the date of the Prospectus and for so long as the delivery of a prospectus is required in connection with the offering or sale of the Additional Notes&#59; to advise the Representatives, promptly </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">13</font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:111%">after it receives notice thereof, of the issuance by the Commission of any stop order or of any order preventing or suspending the use of any Preliminary Prospectus, any Issuer Free Writing Prospectus or the Prospectus, of the suspension of the qualification of the Additional Notes for offering or sale in any jurisdiction, of the initiation or threatening of any proceeding for any such purpose, of any notice from the Commission objecting to the use of the form of the Registration Statement or any post-effective amendment thereto pursuant to Rule 401(g)(2) of the Rules and Regulations, or of any request by the Commission for the amending or supplementing of the Registration Statement, any Issuer Free Writing Prospectus or the Prospectus or for additional information&#59; and, in the event of the issuance of any stop order or of any order preventing or suspending the use of any Preliminary Prospectus, any Issuer Free Writing Prospectus or the Prospectus or suspending any such qualification, to use promptly its reasonable best efforts to obtain its withdrawal&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:111%">(b)&#160;&#160;&#160;&#160;To deliver promptly and without charge to the Representatives such number of the following documents as the Representatives shall reasonably request&#58; (A) conformed copies of the Registration Statement as originally filed with the Commission and each amendment thereto (in each case excluding exhibits other than this Agreement and the Indenture), (B) each Preliminary Prospectus, the Prospectus and any amended or supplemented Prospectus, (C) each Issuer Free Writing Prospectus and (D) any document incorporated by reference in the Prospectus (excluding exhibits thereto)&#59; and if the delivery of a prospectus (or in lieu thereof, the notice referred to in Rule 173(a) of the Rules and Regulations) is required at any time after the date hereof in connection with the offering or sale of the Additional Notes or any other securities relating thereto and if at such time any events shall have occurred as a result of which the Prospectus as then amended or supplemented would include an untrue statement of a material fact or omit to state any material fact necessary in order to make the statements therein, in light of the circumstances under which they were made, when such Prospectus (or in lieu thereof, the notice referred to in Rule 173(a) of the Rules and Regulations) is delivered, not misleading, or, if for any other reason it shall be necessary to amend or supplement the Prospectus or to file under the Exchange Act any document incorporated by reference in the Prospectus in order to comply with the Securities Act or the Exchange Act, to notify the Representatives and, upon their reasonable request, to prepare and furnish without charge to each Underwriter and to any dealer in securities as many copies as the Representatives may from time to time reasonably request of an amended or supplemented Prospectus which will correct such statement or omission or effect such compliance or to file such document&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:111%">(c)&#160;&#160;&#160;&#160;To file promptly with the Commission any amendment to the Registration Statement or the Prospectus or any supplement to the Prospectus that may, in the reasonable judgment of the Company or the Representatives, be required by the Securities Act or requested by the Commission&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:111%">(d)&#160;&#160;&#160;&#160;Prior to filing with the Commission any amendment to the Registration Statement or the Prospectus or supplement to the Prospectus, any document incorporated by reference in the Prospectus or any Prospectus pursuant to Rule 424 of the Rules and Regulations, to furnish a copy thereof to the Representatives and Simpson Thacher &#38; Bartlett LLP, as counsel for the Underwriters, and obtain the consent of the Representatives </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">14</font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">to the filing of such amendment or supplement, as applicable (such consent not to be unreasonably withheld)&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">(e)&#160;&#160;&#160;&#160;That, unless it has obtained or will obtain the prior written consent of the Representatives, it has not made and will not make any offer relating to the Additional Notes that would constitute an Issuer Free Writing Prospectus or that would otherwise constitute a &#8220;free writing prospectus&#8221; (as defined in Rule 405 of the Rules and Regulations) that would require filing with the Commission, other than the information contained in the final term sheet prepared and filed pursuant to Section 5(f)&#59; provided that the prior written consent of the parties hereto shall be deemed to have been given in respect of any other free writing prospectuses identified on Schedule 2 hereto.  Any such other free writing prospectus consented to by the Representatives is hereinafter referred to as a &#8220;Permitted Free Writing Prospectus.&#8221;  The Company agrees that (x) it has treated and will treat, as the case may be, each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus (and that each such Permitted Free Writing Prospectus shall be deemed to be an Issuer Free Writing Prospectus for the purposes of this Agreement) and (y) it has complied and will comply, as the case may be, with the requirements of Rules 164 and 433 of the Rules and Regulations applicable to any Permitted Free Writing Prospectus, including in respect of timely filing with the Commission, legending and record keeping&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">(f)&#160;&#160;&#160;&#160;To file a final term sheet for the Additional Notes, containing solely a description of final terms of the Additional Notes and the offering thereof, substantially in the form of Exhibit A hereto, pursuant to Rule 433(d) of the Rules and Regulations within the time frame required by such Rule&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">(g)&#160;&#160;&#160;&#160;If, at any time prior to the filing of a final prospectus pursuant to Rule 424(b), any event occurs as a result of which the Pricing Disclosure Package or any Issuer Free Writing Prospectus would include any untrue statement of a material fact or omit to state any material fact necessary to make the statements therein, in light of the circumstances under which they were made at such time not misleading, to&#58; (i) notify promptly the Representatives so that any use of the Pricing Disclosure Package or such Issuer Free Writing Prospectus may cease until it is amended or supplemented&#59; (ii) amend or supplement the Pricing Disclosure Package or such Issuer Free Writing Prospectus to correct such statement or omission&#59; and (iii) supply any amendment or supplement to the Underwriters in such quantities as the Representatives may reasonably request&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">(h)&#160;&#160;&#160;&#160;As soon as practicable, to make generally available to the Company&#8217;s security holders and to deliver to the Representatives an earnings statement of the Company and its subsidiaries (which need not be audited) complying with Section 11(a) of the Securities Act and the Rules and Regulations (including, at the option of the Company, Rule 158 of the Rules and Regulations)&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">(i)&#160;&#160;&#160;&#160;For so long as any of the Additional Notes are outstanding, to furnish and deliver without charge to the Representatives and the Trustee, copies of all materials furnished or otherwise made available by the Company to its stockholders and all public reports and all reports and financial statements furnished by the Company to any national securities exchange pursuant to the requirements of or agreements with such exchange or </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">15</font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">to the Commission pursuant to the Exchange Act or any rule or regulation of the Commission thereunder (such materials, reports and financial statements collectively, the &#8220;Reports&#8221;)&#59; provided, however, that the obligations of the Company shall be considered satisfied for the purposes of this Section 5(i) so long as the Company shall file such Reports electronically with the Commission pursuant to Regulation S-T under the Rules and Regulations, and such Reports shall be publicly available&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(j)&#160;&#160;&#160;&#160;Promptly from time to time to take such action as the Representatives may reasonably request to qualify the Additional Notes for offering and sale under the securities laws of such jurisdictions as the Representatives may reasonably request and to comply with such laws so as to permit the continuance of sales and dealings therein in such jurisdictions for as long as may be necessary to complete the distribution of the Additional Notes&#59; provided that, in connection therewith, the Company shall not be required to qualify as a foreign corporation or to file a general consent to service of process in any jurisdiction&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(k)&#160;&#160;&#160;&#160;For the period from the date of the Prospectus until the Delivery Date, not to, directly or indirectly, offer for sale, sell, grant any option to purchase, issue or otherwise transfer or dispose of (or enter into any transaction or device which is designed to, or could be expected to, result in the disposition by any person at any time in the future of) any debt securities of, or guaranteed by, any of the Company or its subsidiaries which are substantially similar to the Additional Notes (other than the Additional Notes), in each case, without the prior written consent of the Representatives&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(l)&#160;&#160;&#160;&#160;To apply the net proceeds from the sale of the Additional Notes being sold by the Company as set forth in the Pricing Disclosure Package and the Prospectus&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(m)&#160;&#160;&#160;&#160;To take such steps as shall be necessary to ensure that neither the Company nor any subsidiary shall become an &#8220;investment company&#8221; (as such term is used under the Investment Company Act and the rules and regulations of the Commission thereunder)&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(n)&#160;&#160;&#160;&#160;To not take, directly or indirectly, any action which is designed to stabilize or manipulate, or which constitutes or which might reasonably be expected to cause or result in stabilization or manipulation, of the price of any security of the Company in connection with the offering of the Additional Notes.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">6.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Expenses.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  The Company agrees to pay (a) the costs incident to the authorization, issuance, sale and delivery of the Additional Notes and any taxes payable in connection therewith&#59; (b) the costs incident to the preparation, printing and filing under the Securities Act of the Registration Statement and exhibits thereto, any Preliminary Prospectus, any Issuer Free Writing Prospectus, the Prospectus and any amendment or supplement thereto&#59; (c) the costs of distributing the Registration Statement as originally filed and each amendment thereto and any post-effective amendments thereof (including, in each case, exhibits), any Preliminary Prospectus, any Issuer Free Writing Prospectus, the Prospectus and any amendment or supplement to the Prospectus or any document incorporated by reference therein, all as provided in this Agreement&#59; (d) the costs of producing and distributing this Agreement and any other related documents in connection with the offering, purchase, sale and delivery of the Additional Notes&#59; </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">16</font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">(e) any applicable listing or similar fees&#59; (f) the fees and expenses of Fried, Frank, Harris, Shriver &#38; Jacobson LLP, counsel to the Company, and of PricewaterhouseCoopers LLP&#59; (g) if applicable, the fees and expenses of qualifying the Additional Notes under the securities laws of the several jurisdictions as provided in Section 5(j) of this Agreement, including, without limitation, the cost of preparing any Blue Sky application or other document prepared or executed by the Company (or based upon any written information furnished by the Company for use therein) specifically for the purpose of qualifying any or all of the Additional Notes under the securities laws of any state or other jurisdiction (any such application, document or information, a &#8220;Blue Sky Application&#8221;) and of preparing, printing and distributing a Blue Sky Memorandum (including related fees and expenses of Simpson Thacher &#38; Bartlett LLP, counsel to the Underwriters)&#59; (h) the cost of &#8220;road show&#8221; presentation materials&#59; and (i) all other costs and expenses incident to the performance of the obligations of the Company under this Agreement&#59; provided that, except as provided in Section 8 and in Section 11, the Underwriters shall pay their own costs and expenses, including the costs and expenses of their counsel, any transfer taxes on the Additional Notes which they may sell and the expenses of advertising any offering of the Additional Notes made by the Underwriters. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">7.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:113%">Conditions of Underwriters&#8217; Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">.  The respective obligations of the Underwriters hereunder are subject to the accuracy, when made and on the Delivery Date, of the representations and warranties of the Company contained herein, to the performance by the Company of its obligations hereunder, and to each of the following additional terms and conditions&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">(a)&#160;&#160;&#160;&#160;The Prospectus shall have been timely filed with the Commission in accordance with Section 5(a)&#59; the Company shall have complied with all filing requirements applicable to any Issuer Free Writing Prospectus&#59; no stop order suspending the effectiveness of the Registration Statement or any part thereof or preventing or suspending the use of the Prospectus or any Issuer Free Writing Prospectus shall have been issued and no proceeding for that purpose shall have been initiated or threatened by the Commission&#59; any request of the Commission for inclusion of additional information in the Registration Statement or the Prospectus or otherwise shall have been complied with&#59; and the Commission shall not have notified the Company of any objection to the use of the form of the Registration Statement pursuant to Rule 401(g)(2) of the Rules and Regulations.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">(b)&#160;&#160;&#160;&#160;No Underwriter shall have discovered and disclosed to the Company on or prior to the Delivery Date that the Registration Statement, the Pricing Disclosure Package or the Prospectus, or any amendment or supplement thereto contains an untrue statement of a fact which, in the opinion of Simpson Thacher &#38; Bartlett LLP, counsel for the Underwriters, is material or omits to state a fact which, in the opinion of such counsel, is material and is required to be stated therein or is necessary to make the statements therein not misleading.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">(c)&#160;&#160;&#160;&#160;The Company shall have furnished to Simpson Thacher &#38; Bartlett LLP, counsel for the Underwriters, all documents and information that they may reasonably request to enable them to pass upon all corporate proceedings and other legal matters incident to the authorization, form and validity of this Agreement, the Indenture, the Additional Notes, the Registration Statement, any Issuer Free Writing Prospectus, the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">17</font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">Pricing Disclosure Package and the Prospectus, and all other legal matters relating to this Agreement and the transactions contemplated hereby.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">(d)&#160;&#160;&#160;&#160;The Representatives shall have received from Simpson Thacher &#38; Bartlett LLP, counsel for the Underwriters, such opinion letter or letters, dated as of the Delivery Date, with respect to the issuance and sale of the Additional Notes, the Registration Statement, the Pricing Disclosure Package, the Prospectus and other related matters as the Representatives may reasonably require.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">(e)&#160;&#160;&#160;&#160;Fried, Frank, Harris, Shriver &#38; Jacobson LLP, counsel to the Company, shall have furnished to the Representatives its written opinion letter or letters, addressed to the Underwriters and dated the Delivery Date, in form and substance reasonably satisfactory to the Representatives.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">(f)&#160;&#160;&#160;&#160;Joseph C. Ventura, Chief Legal Officer to the Company, shall have furnished to the Representatives his written opinion letter, addressed to the Underwriters and dated the Delivery Date, in form and substance reasonably satisfactory to the Representatives. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">(g)&#160;&#160;&#160;&#160;Concurrently with the execution of this Agreement, the Representatives shall have received from PricewaterhouseCoopers LLP a letter, in form and substance reasonably satisfactory to the Representatives, addressed to the Underwriters and dated the date hereof (i) confirming that it is an independent registered public accounting firm within the meaning of the Securities Act and the applicable rules and regulations adopted by the Commission and the Public Company Accounting Oversight Board (United States) and is in compliance with the applicable requirements relating to the qualification of accountants under Rule 2-01 of Regulation S-X of the Commission, and (ii) stating, as of the date hereof (or, with respect to matters involving changes or developments since the respective dates as of which specified financial information is given in the most recent Preliminary Prospectus, as of a date not more than five days prior to the date hereof), the conclusions and findings of such firm with respect to the financial information contained in such Preliminary Prospectus and other matters ordinarily covered by accountants&#8217; &#8220;comfort letters&#8221; to underwriters in connection with registered public offerings.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">(h)&#160;&#160;&#160;&#160;With respect to the letter of PricewaterhouseCoopers LLP referred to in the preceding paragraph and delivered to the Representatives concurrently with the execution of this Agreement (the &#8220;initial letter&#8221;), the Company shall have furnished to the Representatives a letter (the &#8220;bring-down letter&#8221;) of such accountants, addressed to the Underwriters and dated the Delivery Date (i) confirming that it is an independent registered public accounting firm within the meaning of the Securities Act and the applicable rules and regulations adopted by the Commission and the Public Company Accounting Oversight Board (United States) and is in compliance with the applicable requirements relating to the qualification of accountants under Rule 2-01 of Regulation S-X of the Commission, (ii) stating, as of the date of the bring-down letter (or, with respect to matters involving changes or developments since the respective dates as of which specified financial information is given in the Prospectus, as of a date not more than five days prior to the date of the bring-down letter), the conclusions and findings of such firm with respect </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">18</font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">to the financial information contained in the Prospectus and other matters of the type covered by the initial letter and (iii) confirming in all material respects the conclusions and findings set forth in the initial letter.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">(i)&#160;&#160;&#160;&#160;The Company shall have furnished to the Representatives a certificate, dated the Delivery Date, of two officers of the Company satisfactory to the Representatives stating that&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">(i)&#160;&#160;&#160;&#160;The representations, warranties and agreements of the Company in Section 1 of this Agreement that are qualified as to materiality are true and correct as of the Delivery Date and the representations, warranties and agreements of the Company in Section 1 that are not qualified as to materiality are true and correct in all material respects as of the Delivery Date&#59; the Company has complied with all its agreements contained herein&#59; and the conditions set forth in Section 7(a) and (j) have been fulfilled&#59;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:113%;position:relative;top:-4.2pt;vertical-align:baseline"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">and</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">(ii)&#160;&#160;&#160;&#160;They have carefully examined the Registration Statement, the Pricing Disclosure Package and the Prospectus and, in their opinion (A) as of (1) each applicable Effective Date the Registration Statement did not, (2) the Time of Sale the Pricing Disclosure Package did not, and as of the Delivery Date the Pricing Disclosure Package does not, and (3) its date the Prospectus did not, and as of the Delivery Date the Prospectus does not, in each case, include any untrue statement of a material fact and did not omit to state a material fact required to be stated therein or necessary to make the statements therein (except in the case of the Registration Statement, in light of the circumstances under which they were made) not misleading, and (B) since the applicable Effective Date no event has occurred which should have been set forth in a supplement or amendment to the Registration Statement which was not so set forth.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">(j)&#160;&#160;&#160;&#160;(i) Neither the Company nor any of its subsidiaries shall have sustained since the date of the latest audited financial statements included or incorporated by reference in the Preliminary Prospectus any loss or interference with its business from fire, explosion, flood or other calamity, whether or not covered by insurance, or from any labor dispute or court or governmental action, order or decree, otherwise than as set forth in the Preliminary Prospectus and the Prospectus or (ii) since such date there shall not have been any change in the capital stock or long-term debt of the Company or any of its subsidiaries or any change, in or affecting the business, properties, results of operations, financial condition or prospects of the Company and its subsidiaries, taken as a whole, otherwise than as set forth in the Preliminary Prospectus and the Prospectus, the effect of which, in any such case described in clause (i) or (ii), is, in the judgment of the Representatives, so material and adverse as to make it impracticable or inadvisable to proceed with the public offering or the delivery of the Additional Notes being delivered on the Delivery Date on the terms and in the manner contemplated in the Pricing Disclosure Package and the Prospectus.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">(k)&#160;&#160;&#160;&#160;Subsequent to the execution and delivery of this Agreement (i) no downgrading shall have occurred in the rating accorded the Company&#8217;s debt securities by </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">19</font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">any &#8220;nationally recognized statistical rating organization&#8221;, as that term is defined in Section 3(a)(62) of the Exchange Act and (ii) no such organization shall have publicly announced that it has under surveillance or review, with possible negative implications, its rating of any of the Company&#8217;s debt securities.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(l)&#160;&#160;&#160;&#160;Subsequent to the execution and delivery of this Agreement there shall not have occurred any of the following&#58; (i) trading in securities generally on the New York Stock Exchange or in the over-the-counter market, or trading in any securities issued or guaranteed by the Company on any exchange or in the over-the-counter market, shall have been suspended or materially limited or minimum prices shall have been established on any such exchange or such market by the Commission, by such exchange or by any other regulatory body or governmental authority having jurisdiction, (ii) a banking moratorium shall have been declared by federal or New York state authorities, (iii) a material disruption in commercial banking or securities settlement or clearance services has occurred, or (iv) there shall have been a declaration of a national emergency or war by the United States or there shall have occurred any outbreak or escalation of hostilities or any change in financial markets or any calamity or crisis, either within or outside the United States, that, in the judgment of the Representatives, is material and adverse and makes it impracticable or inadvisable to proceed with the public offering, sale or delivery of the Additional Notes being delivered on the Delivery Date on the terms and in the manner contemplated by this Agreement, the Pricing Disclosure Package and the Prospectus.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(m)&#160;&#160;&#160;&#160;No default or event which, with notice or lapse of time or both, would constitute such a default shall have occurred and be continuing, or would result from the transactions contemplated hereby prior to, concurrently with or immediately following the consummation of the offering of the Additional Notes under the Indenture. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(n)&#160;&#160;&#160;&#160;The Additional Notes shall have been duly executed and delivered by the Company and authenticated by the Trustee.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">All opinions, letters, evidence and certificates mentioned above or elsewhere in this Agreement shall be deemed to be in compliance with the provisions hereof only if they are in form and substance reasonably satisfactory to Simpson Thacher &#38; Bartlett LLP, counsel for the Underwriters.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">8.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Indemnification and Contribution.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(a)&#160;&#160;&#160;&#160;The Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">shall indemnify and hold harmless each Underwriter, its directors, officers, employees, agents and affiliates, and each person, if any, who controls any Underwriter within the meaning of the Securities Act, from and against any loss, claim, damage or liability, joint or several, or any action in respect thereof (including, but not limited to, any loss, claim, damage, liability or action relating to purchases and sales of the Additional Notes), to which that Underwriter, director, officer, employee, agent, affiliate or controlling person may become subject, under the Securities Act or otherwise, insofar as such loss, claim, damage, liability or action arises out of, or is based upon, (i) any untrue statement or alleged untrue statement of a material fact contained in the Registration Statement, any Issuer Free Writing Prospectus, any Preliminary Prospectus or the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">20</font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">Prospectus or in any amendment or supplement thereto (ii) the omission or alleged omission to state in the Registration Statement, any Issuer Free Writing Prospectus, any Preliminary Prospectus or the Prospectus, or in any amendment or supplement thereto any material fact required to be stated therein or necessary to make the statements therein not misleading or (iii) any act or failure to act or any alleged act or failure to act by any Underwriter in connection with, or relating in any manner to, the Additional Notes or the offering contemplated hereby, and which is included as part of or referred to in any loss, claim, damage, liability or action arising out of or based upon matters covered by clause (i) or (ii) above (provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:113%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">that the Company shall not be liable under this clause (iii) to the extent that it is determined in a final judgment by a court of competent jurisdiction that such loss, claim, damage, liability or action resulted directly from any such acts or failures to act undertaken or omitted to be taken by such Underwriter through its negligence or willful misconduct), and shall reimburse each Underwriter and each such director, officer, employee, agent, affiliate or controlling person promptly upon demand for any legal or other expenses reasonably incurred by that Underwriter, director, officer, employee, agent, affiliate or controlling person in connection with investigating or defending or preparing to defend against any such loss, claim, damage, liability or action as such expenses are incurred&#59; provided, however, that the Company shall not be liable in any such case to the extent that any such loss, claim, damage, liability or action arises out of, or is based upon, any untrue statement or alleged untrue statement or omission or alleged omission made in the Registration Statement, any Issuer Free Writing Prospectus, any Preliminary Prospectus or the Prospectus, or in any such amendment or supplement, in reliance upon and in conformity with the Underwriters&#8217; Information.  The foregoing indemnity agreement is in addition to any liability that the Company may otherwise have to any Underwriter or to any director, officer, employee, agent, affiliate or controlling person of that Underwriter.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">(b)&#160;&#160;&#160;&#160;Each Underwriter, severally and not jointly, shall indemnify and hold harmless the Company, its directors, officers and employees, and each person, if any, who controls the Company within the meaning of the Securities Act, from and against any loss, claim, damage or liability, joint or several, or any action in respect thereof, to which the Company or any such director, officer, employee or controlling person may become subject, under the Securities Act or otherwise, insofar as such loss, claim, damage, liability or action arises out of, or is based upon, (i) any untrue statement or alleged untrue statement of a material fact contained in any Issuer Free Writing Prospectus, any Preliminary Prospectus or the Prospectus or in any amendment or supplement thereto or (ii) the omission or alleged omission to state in any Issuer Free Writing Prospectus, any Preliminary Prospectus or the Prospectus, or in any amendment or supplement thereto any material fact required to be stated therein or necessary to make the statements therein not misleading, but in each case only to the extent that the untrue statement or alleged untrue statement or omission or alleged omission was made in reliance upon and in conformity with the Underwriters&#8217; Information, and shall reimburse the Company and any such director, officer, employee or controlling person for any legal or other expenses reasonably incurred by the Company or any such director, officer, employee or controlling person in connection with investigating or defending or preparing to defend against any such loss, claim, damage, liability or action as such expenses are incurred.  The foregoing indemnity </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">21</font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">agreement is in addition to any liability that any Underwriter may otherwise have to the Company or any such director, officer, employee or controlling person.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">(c)&#160;&#160;&#160;&#160;Promptly after receipt by an indemnified party under this Section 8 of notice of any claim or the commencement of any action, the indemnified party shall, if a claim in respect thereof is to be made against the indemnifying party under this Section 8, notify the indemnifying party in writing of the claim or the commencement of that action&#59; provided, however, that the failure to notify the indemnifying party shall not relieve it from any liability which it may have under this Section 8 except to the extent it has been materially prejudiced by such failure&#59; and, provided further, that the failure to notify the indemnifying party shall not relieve it from any liability which it may have to an indemnified party otherwise than under this Section 8.  If any such claim or action shall be brought against an indemnified party, and it shall notify the indemnifying party thereof, the indemnifying party shall be entitled to participate therein and, to the extent that it wishes, jointly with any other similarly notified indemnifying party, to assume the defense thereof with counsel reasonably satisfactory to the indemnified party.  After notice from the indemnifying party to the indemnified party of its election to assume the defense of such claim or action, the indemnifying party shall not be liable to the indemnified party under this Section 8 for any legal or other expenses subsequently incurred by the indemnified party in connection with the defense thereof other than reasonable costs of investigation&#59; provided, however, that the Representatives shall have the right to employ counsel to represent jointly the Representatives and those other Underwriters and their respective directors, officers, employees, agents, affiliates and controlling persons who may be subject to liability arising out of any claim in respect of which indemnity may be sought by the Underwriters against the Company under this Section 8 if, in the reasonable judgment of the Representatives, it is advisable for the Representatives and those Underwriters, directors, officers, employees, agents, affiliates and controlling persons to be jointly represented by separate counsel, and in that event the fees and expenses of such separate counsel shall be paid by the Company.  No indemnifying party shall (i) without the prior written consent of the indemnified parties (which consent shall not be unreasonably withheld), settle or compromise or consent to the entry of any judgment with respect to any pending or threatened claim, action, suit or proceeding in respect of which indemnification or contribution may be sought hereunder (whether or not the indemnified parties are actual or potential parties to such claim or action) unless such settlement, compromise or consent includes an unconditional release of each indemnified party from all liability arising out of such claim, action, suit or proceeding, or (ii) be liable for any settlement of any such action effected without its written consent (which consent shall not be unreasonably withheld), but if settled with the consent of the indemnifying party or if there be a final judgment of the plaintiff in any such action, the indemnifying party agrees to indemnify and hold harmless any indemnified party from and against any loss or liability by reason of such settlement or judgment.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">(d)&#160;&#160;&#160;&#160;If the indemnification provided for in this Section 8 shall for any reason be unavailable to or insufficient to hold harmless an indemnified party under Section 8(a) or 8(b) in respect of any loss, claim, damage or liability, or any action in respect thereof, referred to therein, then each indemnifying party shall, in lieu of indemnifying such indemnified party, contribute to the amount paid or payable by such indemnified party as </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">22</font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">a result of such loss, claim, damage or liability, or action in respect thereof, (i) in such proportion as shall be appropriate to reflect the relative benefits received by the Company on the one hand and the Underwriters on the other from the offering of the Additional Notes or (ii) if the allocation provided by clause (i) above is not permitted by applicable law, in such proportion as is appropriate to reflect not only the relative benefits referred to in clause (i) above but also the relative fault of the Company on the one hand and the Underwriters on the other with respect to the statements or omissions which resulted in such loss, claim, damage or liability, or action in respect thereof, as well as any other relevant equitable considerations.  The relative benefits received by the Company on the one hand and the Underwriters on the other with respect to such offering shall be deemed to be in the same proportion as the total net proceeds from the offering of the Additional Notes purchased under this Agreement (before deducting expenses) received by the Company, on the one hand, and the total underwriting discounts and commissions received by the Underwriters with respect to the Additional Notes purchased under this Agreement, on the other hand, bear to the total gross proceeds from the offering of the Additional Notes under this Agreement, in each case as set forth in the table on the cover page of the Prospectus.  The relative fault shall be determined by reference to whether the untrue or alleged untrue statement of a material fact or omission or alleged omission to state a material fact relates to information supplied by the Company or the Underwriters, the intent of the parties and their relative knowledge, access to information and opportunity to correct or prevent such statement or omission.  The Company and the Underwriters agree that it would not be just and equitable if contributions pursuant to this Section 8 were to be determined by pro rata allocation (even if the Underwriters were treated as one entity for such purpose) or by any other method of allocation which does not take into account the equitable considerations referred to herein.  The amount paid or payable by an indemnified party as a result of the loss, claim, damage or liability, or action in respect thereof, referred to above in this Section 8 shall be deemed to include, for purposes of this Section 8, any legal or other expenses reasonably incurred by such indemnified party in connection with investigating or defending any such action or claim.  Notwithstanding the provisions of this Section 8, no Underwriter shall be required to contribute any amount in excess of the amount by which the total price at which the Additional Notes underwritten by it and distributed to the public was offered to the public exceeds the amount of any damages which such Underwriter has otherwise paid or become liable to pay by reason of any untrue or alleged untrue statement or omission or alleged omission.  No person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation.  The Underwriters&#8217; obligations to contribute as provided in this Section 8 are several in proportion to their respective underwriting obligations and not joint.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">(e)&#160;&#160;&#160;&#160;The Underwriters severally confirm and the Company acknowledges that the statements with respect to the public offering of the Additional Notes by the Underwriters set forth in the fifth paragraph, the fourth sentence of the seventh paragraph and the eighth, ninth and tenth paragraphs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:113%;position:relative;top:-4.2pt;vertical-align:baseline"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">under the caption &#8220;Underwriting&#8221; in the Prospectus Supplement are correct and constitute the only information concerning such Underwriters furnished in writing to the Company through the Representatives by or on behalf of the Underwriters specifically for inclusion in the Pricing Disclosure Package, any Issuer Free Writing Prospectus or the Prospectus (the &#8220;Underwriters&#8217; Information&#8221;).</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">23</font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">9.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:113%">Defaulting Underwriters</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">.  If, on the Delivery Date, any Underwriter defaults in the performance of its obligations under this Agreement, the remaining non-defaulting Underwriters shall be obligated to purchase the Additional Notes which the defaulting Underwriter agreed but failed to purchase on the Delivery Date in the respective proportions which the aggregate principal amount of Additional Notes set opposite the name of each remaining non-defaulting Underwriter in Schedule 1 hereto bears to the total aggregate principal amount of Additional Notes set opposite the names of all the remaining non-defaulting Underwriters in Schedule 1 hereto&#59; provided, however, that the remaining non-defaulting Underwriters shall not be obligated to purchase any of the Additional Notes on the Delivery Date if the total aggregate principal amount of Additional Notes which the defaulting Underwriter or Underwriters agreed but failed to purchase on such date exceeds 9.09% of the total aggregate principal amount of Additional Notes to be purchased on the Delivery Date, and any remaining non-defaulting Underwriter shall not be obligated to purchase more than 110% of the aggregate principal amount of Additional Notes which it agreed to purchase on the Delivery Date pursuant to the terms of Section 2.  If the foregoing maximums are exceeded, the remaining non-defaulting Underwriters, or those other underwriters satisfactory to the Representatives who so agree, shall have the right, but shall not be obligated, to purchase, in such proportion as may be agreed upon among them, all the Additional Notes to be purchased on the Delivery Date.  If the remaining Underwriters or other underwriters satisfactory to the Representatives do not elect to purchase Additional Notes which the defaulting Underwriter or Underwriters agreed but failed to purchase on the Delivery Date, this Agreement shall terminate without liability on the part of any non-defaulting Underwriter or the Company, except that the Company will continue to be liable for the payment of expenses of the non-defaulting Underwriters to the extent set forth in Sections 6 and 11.  As used in this Agreement, the term &#8220;Underwriter&#8221; includes, for all purposes of this Agreement unless the context requires otherwise, any party not listed in Schedule 1 hereto who, pursuant to this Section 9, purchases the Additional Notes which a defaulting Underwriter agreed but failed to purchase.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">Nothing contained herein shall relieve a defaulting Underwriter of any liability it may have to the Company for damages caused by its default.  If other underwriters are obligated or agree to purchase the Additional Notes of a defaulting or withdrawing Underwriter, either the Representatives or the Company may postpone the Delivery Date for up to seven full business days in order to effect any changes that in the opinion of counsel for the Company or counsel for the Underwriters may be necessary in the Registration Statement, the Prospectus or in any other document or arrangement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">10.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:113%">Termination.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">&#160;&#160;&#160;&#160;The obligations of the Underwriters hereunder may be terminated by the Representatives by notice given to and received by the Company prior to delivery of and payment for the Additional Notes if, prior to that time, (i) any of the events described in Sections 7(j), 7(k) and 7(l) shall have occurred, (ii) the representation in Section 1(g) is incorrect in any respect, or (iii) the Underwriters shall decline to purchase the Additional Notes for any reason permitted under this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">11.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:113%">Reimbursement of Underwriters&#8217; Expenses.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">  If the Company shall fail to tender the Additional Notes for delivery to the Underwriters by reason of any failure, refusal or inability on the part of the Company to perform any agreement on its part to be performed (other than with respect to a termination pursuant to clause (ii) of Section 10 if the Company and the Underwriters subsequently enter into another agreement for the Underwriters to underwrite the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">24</font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">same or substantially similar securities of the Company), or because any other condition of the Underwriters&#8217; obligations hereunder required to be fulfilled by the Company is not fulfilled, the Company will reimburse the Underwriters for all reasonable documented out-of-pocket expenses (including fees and disbursements of counsel) incurred by the Underwriters in connection with this Agreement and the proposed purchase of the Additional Notes, and upon demand the Company shall pay the full amount thereof to the Representatives.  If this Agreement is terminated pursuant to Section 9 by reason of the default of one or more Underwriters, the Company shall not be obligated to reimburse any defaulting Underwriter on account of those expenses.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">12.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Notices, etc.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  All statements, requests, notices and agreements hereunder shall be in writing, and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(a)&#160;&#160;&#160;&#160;if to the Underwriters, shall be delivered or sent by mail, telex or facsimile transmission to&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(i)&#160;&#160;&#160;&#160;J.P. Morgan Securities LLC, 383 Madison Avenue, New York, New York 10179, Attention&#58; High Grade Syndicate Desk &#8211; 3rd Floor (Fax&#58; (212) 834-6081)&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(ii)&#160;&#160;&#160;&#160;Barclays Capital Inc., 745 Seventh Avenue, New York, New York 10019, Attention&#58; Syndicate Registration (Fax&#58; (646) 834-8133)&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">in each case with a copy to Simpson Thacher &#38; Bartlett LLP, 425 Lexington Avenue, New York, New York 10017, Attention&#58; Mark Brod (Fax&#58; (212) 455-2502)&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(b)&#160;&#160;&#160;&#160;if to the Company, shall be delivered or sent by mail, telex or facsimile transmission to the address of the Company set forth in the Registration Statement, Attention&#58; Chief Financial Officer (Fax&#58; (502) 580-3615), with a copy to Fried, Frank, Harris, Shriver &#38; Jacobson LLP, One New York Plaza, New York, New York 10004, Attention&#58; Joshua Wechsler (Fax&#58; (212) 859-4000).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">13.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Persons Entitled to Benefit of Agreement.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  This Agreement shall inure to the benefit of and be binding upon the Underwriters, the Company, and their respective successors.  This Agreement and the terms and provisions hereof are for the sole benefit of only those persons, except that (A) the representations, warranties, indemnities and agreements of the Company contained in this Agreement shall also be deemed to be for the benefit of the person or persons, if any, who control any Underwriter within the meaning of Section 15 of the Securities Act and (B) the indemnity agreement of the Underwriters contained in Section 8(b) of this Agreement shall be deemed to be for the benefit of directors of the Company, officers of the Company who have signed the Registration Statement and any person controlling the Company within the meaning of Section 15 of the Securities Act.  Nothing in this Agreement is intended or shall be construed to give any person, other than the persons referred to in this Section, any legal or equitable right, remedy or claim under or in respect of this Agreement or any provision contained herein.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">14.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Survival.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  The respective indemnities, representations, warranties and agreements of the Company and the Underwriters contained in this Agreement or made by or on </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">25</font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">behalf of them, respectively, pursuant to this Agreement, shall survive the delivery of and payment for the Additional Notes and shall remain in full force and effect, regardless of any investigation made by or on behalf of any of them or any person controlling any of them.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">15.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:113%">Recognition of the U.S. Special Resolution Regimes.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">(a)&#160;&#160;&#160;&#160;In the event that any Underwriter that is a Covered Entity becomes subject to a proceeding under a U.S. Special Resolution Regime, the transfer from such Underwriter of this Agreement, and any interest and obligation in or under this Agreement, will be effective to the same extent as the transfer would be effective under the U.S. Special Resolution Regime if this Agreement, and any such interest and obligation, were governed by the laws of the United States or a state of the United States.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">(b)&#160;&#160;&#160;&#160;In the event that any Underwriter that is a Covered Entity or a BHC Act Affiliate of such Underwriter becomes subject to a proceeding under a U.S. Special Resolution Regime, Default Rights under this Agreement that may be exercised against such Underwriter are permitted to be exercised to no greater extent than such Default Rights could be exercised under the U.S. Special Resolution Regime if this Agreement were governed by the laws of the United States or a state of the United States.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">(c)&#160;&#160;&#160;&#160;For purposes of this Section 15, a &#8220;BHC Act Affiliate&#8221; has the meaning assigned to the term &#8220;affiliate&#8221; in, and shall be interpreted in accordance with, 12 U.S.C. &#167; 1841(k). &#8220;Covered Entity&#8221; means any of the following&#58; (i) a &#8220;covered entity&#8221; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167; 252.82(b)&#59; (ii) a &#8220;covered bank&#8221; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167; 47.3(b)&#59; or (iii) a &#8220;covered FSI&#8221; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167; 382.2(b). &#8220;Default Right&#8221; has the meaning assigned to that term in, and shall be interpreted in accordance with, 12 C.F.R. &#167;&#167; 252.81, 47.2 or 382.1, as applicable. &#8220;U.S. Special Resolution Regime&#8221; means each of (i) the Federal Deposit Insurance Act and the regulations promulgated thereunder and (ii) Title II of the Dodd-Frank Wall Street Reform and Consumer Protection Act and the regulations promulgated thereunder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">16.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:113%">Definitions of &#8220;Business Day&#8221; and &#8220;Subsidiary&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">.  For purposes of this Agreement, (a) &#8220;business day&#8221; means each Monday, Tuesday, Wednesday, Thursday or Friday which is not a day on which banking institutions in New York are generally authorized or obligated by law or executive order to close and (b) &#8220;subsidiary&#8221; has the meaning set forth in Rule 405 of the Rules and Regulations.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">17.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:113%">Governing Law.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:113%">This Agreement shall be governed by, and construed in accordance with, the laws of the State of New York.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">18.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:113%">Counterparts.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">  This Agreement may be executed in one or more counterparts and, if executed in more than one counterpart, the executed counterparts shall each be deemed to be an original but all such counterparts shall together constitute one and the same instrument. The words &#8220;executed,&#8221; &#8220;execution,&#8221; &#8220;signed,&#8221; &#8220;signature,&#8221; &#8220;delivery,&#8221; and words of like import in or relating to this Agreement or any document to be signed in connection with this Agreement shall be deemed to include electronic signatures, deliveries or the keeping of records </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">26</font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">in electronic form, each of which shall be of the same legal effect, validity or enforceability as a manually executed signature, physical delivery thereof or the use of a paper-based recordkeeping system, as the case may be, and the parties hereto consent to conduct the transactions contemplated hereunder by electronic means.</font></div><div style="margin-bottom:24pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">19.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:113%">Headings.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">  The headings herein are inserted for convenience of reference only and are not intended to be part of, or to affect the meaning or interpretation of, this Agreement.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:113%">Signature pages to follow</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">&#93;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i6a0bf2464f934039a01e08067fe5ed83_112"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">If the foregoing correctly sets forth the agreement between the Company and the Underwriters, please indicate your acceptance in the space provided for that purpose below.</font></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:468.00pt"><tr><td style="width:1.0pt"></td><td style="width:218.50pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:21.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:36.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:144.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:37.75pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Very truly yours,</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">HUMANA INC.</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#47;s&#47; Robert Marcoux</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Robert Marcoux</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Vice President and Treasurer</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#91;Signature page to Humana Underwriting Agreement&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">Accepted&#58;</font></div><div style="margin-bottom:24pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">J.P. MORGAN SECURITIES LLC</font></div><div style="margin-bottom:24pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:191.25pt"><tr><td style="width:1.0pt"></td><td style="width:21.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:36.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:127.75pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#47;s&#47; Robert Bottamedi</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Robert Bottamedi</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Executive Director</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">For itself and as a Representative </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">of the several Underwriters named </font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">in Schedule 1 hereto</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#91;Signature page to Humana Underwriting Agreement&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">Accepted&#58;</font></div><div style="margin-bottom:24pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">BARCLAYS CAPITAL INC.</font></div><div style="margin-bottom:24pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:191.25pt"><tr><td style="width:1.0pt"></td><td style="width:21.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:36.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:127.75pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#47;s&#47; James Gutow</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">James Gutow</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Managing Director</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">For itself and as a Representative </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">of the several Underwriters named </font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">in Schedule 1 hereto</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#91;Signature page to Humana Underwriting Agreement&#93;</font></div></div></div><div id="i6a0bf2464f934039a01e08067fe5ed83_133"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:24pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%;text-decoration:underline">SCHEDULE 1</font></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:70.032%"><tr><td style="width:1.0%"></td><td style="width:66.176%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aggregate Principal Amount</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">of Additional Notes</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Underwriters</font></div></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">J.P. Morgan Securities LLC</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$150,000,000</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Barclays Capital Inc.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;$62,500,000</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BofA Securities, Inc.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$12,500,000</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mizuho Securities USA LLC.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$12,500,000</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. Bancorp Investments, Inc.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$12,500,000</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</font></div></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$250,000,000</font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#91;Signature page to Humana Underwriting Agreement&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%;text-decoration:underline">SCHEDULE 2</font></div><div style="margin-bottom:24pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">ISSUER FREE WRITING PROSPECTUSES</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">(A) Issuer Free Writing Prospectuses considered part of the Pricing Disclosure Package&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:113%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%;padding-left:13.8pt">Term sheet substantially in the form of Exhibit A hereto</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">(B) Issuer Free Writing Prospectuses not considered part of the Pricing Disclosure Package&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:113%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%;padding-left:13.8pt">None</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#91;Signature page to Humana Underwriting Agreement&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%;text-decoration:underline">SCHEDULE 3</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">HUMANA INC.</font></div><div style="margin-bottom:24pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">PARTNERSHIPS&#47;JOINT VENTURES</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:113%;text-decoration:underline">Pennsylvania</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:113%">DVACO-2, LLC, a Pennsylvania limited liability company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">, is the parent company of Accountable Care Organization of Delaware Valley, LLC, a Pennsylvania limited liability company d&#47;b&#47;a Delaware Valley ACO, and DVACO &#8211; 3, a Pennsylvania limited liability company.&#160; Collectively, these entities operate accountable care organizations (&#8220;ACO&#8221;) in certain counties in Pennsylvania.&#160; Humana Inc. owns 51% of the membership interests in DVACO-2, Jefferson Alliance, LLC, owns 24.5% of the membership interests in DVACO-2, and Main Line Health, Inc., owns 24.5% of the membership interests in DVACO-2.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i6a0bf2464f934039a01e08067fe5ed83_154"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:113%">EXHIBIT A</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:113%">HUMANA INC.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:113%"> $250,000,000 5.375% Senior Notes due 2031</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:113%">March 26, 2025</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:113%;text-decoration:underline">Pricing Term Sheet</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Issuer&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Humana Inc.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ratings*&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;Intentionally Omitted&#93;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Trade Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 26, 2025</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Settlement Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(T+3) March 31, 2025</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Active Bookrunners&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.77pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">J.P. Morgan Securities LLC</font></div><div style="padding-right:2.77pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Barclays Capital Inc.</font></div></td></tr></table></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:113%;text-decoration:underline">Additional Notes</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Security Description&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$250,000,000 5.375% Senior Notes due 2031 (the &#8220;Additional Notes&#8221;)</font></div><div style="padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Additional Notes will become part of the same series as the outstanding 5.375% Senior Notes due April 15, 2031, $1,250,000,000 aggregate principal amount of which was originally issued on March 13, 2024, for all purposes.</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Aggregate Principal Amount&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$250,000,000 of the Additional Notes</font></div><div style="padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Immediately after giving effect to the issuance of the Additional Notes and together with the previously issued $1,250,000,000 in aggregate principal amount of the 5.375% Senior Notes due 2031, the total outstanding aggregate principal amount of the 5.375% Senior Notes due 2031 will be $1,500,000,000.</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Coupon&#58;</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.375%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Maturity Date&#58;</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 15, 2031</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Price to Public&#58;</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.941% of the principal amount, plus accrued interest for the period from and including October 15, 2024 up to but excluding the settlement date</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Benchmark Treasury&#58;</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.000% UST due February 28, 2030</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Benchmark Treasury Price &#47; Yield&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">99-19 &#190; </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.086</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">% </font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Spread to Benchmark Treasury&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.77pt;padding-right:2.77pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">+</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">130</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> bps</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Yield to Maturity&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.386</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Interest Payment Dates&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">April 15 </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">October 15, commencing April 15, 2025</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Optional Redemption&#58;</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Make-whole call at T+20 bps plus accrued and unpaid interest </font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Par Call&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On or after February 15</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, 20</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CUSIP&#47;ISIN&#58;</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">444859 CA8 &#47; US444859CA81</font></td></tr></table></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:113%">___________________</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:113%">*Note&#58; A securities rating is not a recommendation to buy, sell or hold securities and may be subject to revision or withdrawal at any time.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:113%">The issuer has filed a registration statement (including a prospectus) with the SEC for the offering to which this communication relates.  Before you invest, you should read the prospectus in that registration statement, the preliminary prospectus supplement thereto relating to the Additional Notes and other documents the issuer has filed with the SEC for more complete information about the issuer and this offering.  You may get these documents for free by visiting EDGAR on the SEC Web site at www.sec.gov.  Alternatively, the issuer, any underwriter or any dealer participating in the offering will arrange to send you the prospectus and the preliminary prospectus supplement thereto relating to the Additional Notes if you request it by calling J.P. Morgan Securities LLC collect at (212) 834-4533 or Barclays Capital Inc. toll-free at (888) 603-5847.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:113%">Any disclaimer or other notice that may appear below is not applicable to this communication and should be disregarded.  Such disclaimer or notice was automatically generated as a result of this communication being sent by Bloomberg or another email system.</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:113%"> </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>3
<FILENAME>exhibit51-8xk.htm
<DESCRIPTION>EX-5.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i8a46afff264b40ce9eb6f0c578b5c9af_1"></div><div style="min-height:126pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 5.1</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.989%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.310%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.401%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">FRIED, FRANK, HARRIS, SHRIVER &#38; JACOBSON LLP</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:8pt;text-align:right"><img alt="fflogo.jpg" src="fflogo.jpg" style="height:101px;margin-bottom:5pt;vertical-align:text-bottom;width:76px"></div></td></tr></table></div></div><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">March 31, 2025</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Humana Inc.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">500 West Main Street</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Louisville, Kentucky 40202</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Ladies and Gentlemen&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">We are acting as counsel to Humana Inc., a Delaware corporation (the &#8220;Company&#8221;), in connection with the Registration Statement on Form S-3 (File No. 333-277734) (the &#8220;Registration Statement&#8221;), under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), with respect to the additional issuance of $250,000,000 in aggregate principal amount of 5.375% Senior Notes due 2031 (the &#8220;Additional Debt Securities&#8221;) of the Company. The Additional Debt Securities are being offered and sold by the Company in a public offering pursuant to an underwriting agreement dated March 26, 2025 by and among the Company and J.P. Morgan Securities LLC and Barclays Capital Inc., as representatives of the underwriters named therein (the &#8220;Underwriting Agreement&#8221;) and will be an additional issuance of the 5.375% Senior Notes due 2031 that the Company issued in aggregate principal amount of $1,250,000,000 on March 13, 2024 (together with the Additional Debt Securities, the &#8220;Debt Securities&#8221;), with such Debt Securities having an aggregate principal amount of $1,500,000,000 following consummation of this offering. With your permission, all assumptions and statements of reliance herein have been made without any independent investigation or verification on our part, and we express no opinion with respect to the subject matter or accuracy of such assumptions or items relied upon.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Additional Debt Securities have been issued pursuant to a senior debt indenture, dated as of August 5, 2003, by and between the Company and The Bank of New York Trust Company, N.A. (formerly known as The Bank of New York Trust Company, N.A.) (as successor to The Bank of New York), as trustee (the &#8220;Trustee&#8221;) (as supplemented by the Twenty-Eighth Supplemental Indenture dated as of March 13, 2024, the &#8220;Indenture&#8221;).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">In connection with this opinion, we have (i) investigated such questions of law, (ii)&#160;examined the originals or certified, conformed, electronic or reproduction copies of such agreements, instruments, documents and records of the Company and its subsidiaries, such certificates of public officials and such other documents and (iii) received such information from officers and representatives of the Company and its subsidiaries and others, in each case, as we have deemed necessary or appropriate for the purposes of this opinion. We examined, among other documents, the following&#58;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.7pt">an executed copy of the Underwriting Agreement&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt">an executed copy of the Indenture&#59; </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:139%">One New York Plaza, New York, New York 10004&#8212;1980</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">T&#58;  +1.212.859.8000  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">friedfrank.com</font></div></div></div><div id="i8a46afff264b40ce9eb6f0c578b5c9af_88"></div><hr style="page-break-after:always"><div style="min-height:90pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.608%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.859%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">FRIED, FRANK, HARRIS, SHRIVER &#38; JACOBSON LLP</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">March 31, 2025</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Page 2</font></div></td></tr></table></div></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.7pt">executed copies of the Additional Debt Securities.</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt">the officer&#8217;s certificate of the Company, dated March 13, 2024, delivered to the Trustee in relation to the Debt Securities&#59; and</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.7pt">the officer&#8217;s certificate of the Company, dated March 31, 2025, delivered to the Trustee in relation to the authentication, execution and delivery of the Additional Debt Securities.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The documents referred to in items (a) through (e) above, inclusive, are collectively referred to as the &#8220;Documents.&#8221;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">In all such examinations, we have assumed the legal capacity of all natural persons, the genuineness of all signatures, the authenticity of original and certified documents and the conformity to original or certified documents of all copies submitted to us as conformed, electronic or reproduction copies. As to various questions of fact relevant to the opinion expressed herein, we have relied upon, and assume the accuracy of, representations and warranties contained in the Documents and certificates and oral or written statements and other information of or from public officials, officers or representatives of the Company and its subsidiaries and others.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">To the extent it may be relevant to the opinion expressed herein, we have assumed that (i) the Additional Debt Securities have been duly authenticated and delivered by the Trustee in accordance with the terms of the Indenture against payment therefor in accordance with the terms of the Underwriting Agreement&#59; (ii) all of the parties to the Documents (other than the Company) are validly existing and in good standing under the laws of their respective jurisdictions of organization and have the power and authority to (a) execute and deliver the Documents, (b) perform their obligations thereunder and (c) consummate the transactions contemplated thereby&#59; (iii) each of the Documents has been duly authorized, executed and delivered by all of the parties thereto (other than the Company), and each of the Documents constitutes a valid and binding obligation of all the parties thereto (other than as expressly addressed in the opinion below as to the Company) enforceable against such parties in accordance with their respective terms&#59; and (iv) all of the parties to the Documents will comply with all of their covenants, agreements and obligations under the Documents and all laws applicable thereto. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Based upon the foregoing, and subject to the limitations, qualifications and assumptions set forth herein, we are of the opinion that the Additional Debt Securities, when paid for by the Underwriters in accordance with the terms of the Underwriting Agreement, will constitute valid and binding obligations of the Company.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:90pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.608%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.859%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">FRIED, FRANK, HARRIS, SHRIVER &#38; JACOBSON LLP</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">March 31, 2025</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Page 3</font></div></td></tr></table></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">We express no opinion as to the validity, binding effect or enforceability of any provision of the Documents&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;relating to indemnification, contribution or exculpation&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;containing any purported waiver, release, variation, disclaimer, consent or other agreement of similar effect (all of the foregoing, collectively, a &#8220;Waiver&#8221;) by the Company under any of such Documents to the extent limited by provisions of applicable law (including judicial decisions), or to the extent that such a Waiver applies to a right, claim, duty, defense or ground for discharge otherwise existing or occurring as a matter of law (including judicial decisions), except to the extent that such a Waiver is effective under, and is not prohibited by or void or invalid under, provisions of applicable law (including judicial decisions)&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(iii)&#160;&#160;&#160;&#160;related to (a) forum selection or submission to jurisdiction (including, without limitation, any waiver of any objection to venue in any court or of any objection that a court is an inconvenient forum) to the extent that the validity, binding effect or enforceability of such provision is to be considered by any court other than a court of the State of New York, (b)&#160;choice of governing law to the extent that the validity, binding effect or enforceability of any such provision is to be considered by any court other than a court of the State of New York or a federal district court sitting in the State of New York, in each case, applying the choice of law rules of the State of New York, (c) service of process, or (d) waivers of any rights to trial by jury&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(iv)&#160;&#160;&#160;&#160;specifying that provisions thereof may be modified or waived only in writing&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(v)&#160;&#160;&#160;&#160;purporting to give any person or entity the power to accelerate obligations without notice to the obligor&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(vi)&#160;&#160;&#160;&#160;relating to payment of late charges, interest (or discount or equivalent amounts), premium, &#8220;make-whole&#8221; payments, collection costs or fees at a rate or in an amount, after or upon the maturity or acceleration of the liabilities evidenced or secured thereby or after or during the continuance of any default or other circumstance, or upon prepayment, that a court would determine in the circumstances to be unreasonable, a penalty or forfeiture&#59; or</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(vii)&#160;&#160;&#160;&#160;that purports to create a trust, power of attorney or other fiduciary relationship.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">We express no opinion relating to any matters subject to, or the effect of, any federal, state or local laws, regulations or policies relating to health care, including, but not limited to, licensure, permitting, registrations, certification, and reimbursement (including, but not limited to, Medicare, Medicaid, CHAMPVA, TRICARE, the Patient Protection and Affordable Care Act and any other federal or state health care program or regulatory agency), the Health Insurance Portability and Accountability Act of 1996, the Food, Drug &#38; Cosmetic Act, 42 U.S.C. &#167;1320a7, 7a and 7b, 42 U.S.C. &#167;1395nn, or 31 U.S.C. &#167;3729-3733.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:90pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.608%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.859%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">FRIED, FRANK, HARRIS, SHRIVER &#38; JACOBSON LLP</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">March 31, 2025</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Page 4</font></div></td></tr></table></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">We express no opinion as to the effect of any law of any jurisdiction other than the State of New York wherein any party to the Documents may be located or wherein enforcement of any Documents may be sought that limits the rates or interest legally chargeable or collectible.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">D.&#160;&#160;&#160;&#160;The opinion set forth above is subject to the following qualifications&#58; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:24.69pt">bankruptcy, insolvency, reorganization, moratorium and other laws (or related judicial doctrines) now or hereafter in effect relating to or affecting creditors&#8217; rights or remedies generally&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21.36pt">general principles of equity (including, without limitation, standards of materiality, good faith, fair dealing and reasonableness, equitable defenses and limits as to the availability of equitable remedies), whether such principles are considered in a proceeding in equity or at law&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18.03pt">the application of any applicable fraudulent conveyance, fraudulent transfer, fraudulent obligation or preferential transfer law or any law governing the distribution of assets of any person now or hereafter in effect affecting creditors&#8217; rights and remedies generally.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The opinion expressed herein is limited to the laws of the State of New York and, to the extent relevant, the General Corporation Law of the State of Delaware, each as currently in effect, and no opinion is expressed with respect to any other laws or any effect that such other laws may have on the opinion expressed herein. The opinion expressed herein is limited to the matters stated herein, and no opinion is implied or may be inferred beyond the matters expressly stated herein. This letter is given only as of the time of its delivery, and we undertake no responsibility to update or supplement this letter after its delivery.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">We hereby consent to the filing of this opinion as an exhibit to the Current Report on Form 8-K filed by the Company on the date hereof and its incorporation by reference in the Registration Statement and to references to this firm under the caption &#8220;Legal Matters&#8221; in the Registration Statement and prospectus supplements related to the Additional Debt Securities. In giving this consent, we do not hereby admit that we are in the category of persons whose consent is required under Section 7 of the Securities Act.</font></div><div style="margin-bottom:12pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:72.916%"><tr><td style="width:1.0%"></td><td style="width:90.108%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.692%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">Very truly yours,</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#47;s&#47; FRIED, FRANK, HARRIS, SHRIVER &#38; JACOBSON LLP</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">FRIED, FRANK, HARRIS, SHRIVER &#38; JACOBSON LLP</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>hum-20250326.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:b8d6c879-28c4-42c2-9fee-6c511a7e9ff9,g:db6499c3-a5bf-4115-99d2-37d705b81ee5-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:hum="http://www.humana.com/20250326" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.humana.com/20250326">
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="hum-20250326_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="hum-20250326_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="hum-20250326_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="DocumentandEntityInformationDocument" roleURI="http://www.humana.com/role/DocumentandEntityInformationDocument">
        <link:definition>0000001 - Document - Document and Entity Information Document</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>5
<FILENAME>hum-20250326_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:b8d6c879-28c4-42c2-9fee-6c511a7e9ff9,g:db6499c3-a5bf-4115-99d2-37d705b81ee5-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.humana.com/role/DocumentandEntityInformationDocument" xlink:type="simple" xlink:href="hum-20250326.xsd#DocumentandEntityInformationDocument"/>
  <link:definitionLink xlink:role="http://www.humana.com/role/DocumentandEntityInformationDocument" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems_7d86fe80-0b7c-4d6e-924f-9238f8ee8845" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable_6467a976-fc77-43a3-8693-a004d26257b1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_EntityInformationLineItems_7d86fe80-0b7c-4d6e-924f-9238f8ee8845" xlink:to="loc_dei_EntitiesTable_6467a976-fc77-43a3-8693-a004d26257b1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_641d440a-f1e0-4855-9162-2ef29f59d46f" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_7d86fe80-0b7c-4d6e-924f-9238f8ee8845" xlink:to="loc_dei_DocumentType_641d440a-f1e0-4855-9162-2ef29f59d46f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_099f3e2f-9d0d-4e2f-ac58-02e4f8398e77" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_7d86fe80-0b7c-4d6e-924f-9238f8ee8845" xlink:to="loc_dei_DocumentPeriodEndDate_099f3e2f-9d0d-4e2f-ac58-02e4f8398e77" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_192a2493-9324-46c1-b9c1-724a8f22b8bd" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_7d86fe80-0b7c-4d6e-924f-9238f8ee8845" xlink:to="loc_dei_EntityRegistrantName_192a2493-9324-46c1-b9c1-724a8f22b8bd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_c673e1fc-6773-43a3-925a-365e1cca5765" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_7d86fe80-0b7c-4d6e-924f-9238f8ee8845" xlink:to="loc_dei_EntityIncorporationStateCountryCode_c673e1fc-6773-43a3-925a-365e1cca5765" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_4fdbd8cb-a0b3-4aef-bdb6-20016835ac9b" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_7d86fe80-0b7c-4d6e-924f-9238f8ee8845" xlink:to="loc_dei_EntityFileNumber_4fdbd8cb-a0b3-4aef-bdb6-20016835ac9b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_606fb398-063a-42bc-8b0b-a9ffb5d70dd7" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_7d86fe80-0b7c-4d6e-924f-9238f8ee8845" xlink:to="loc_dei_EntityTaxIdentificationNumber_606fb398-063a-42bc-8b0b-a9ffb5d70dd7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_eeef2028-a88c-44e5-ab45-4490a2dbbdf5" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_7d86fe80-0b7c-4d6e-924f-9238f8ee8845" xlink:to="loc_dei_EntityAddressAddressLine1_eeef2028-a88c-44e5-ab45-4490a2dbbdf5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_5e89ba77-ab04-4d06-82d2-e06f80448a9c" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_7d86fe80-0b7c-4d6e-924f-9238f8ee8845" xlink:to="loc_dei_EntityAddressCityOrTown_5e89ba77-ab04-4d06-82d2-e06f80448a9c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_3cdf37e6-608a-454e-9f09-81b919d778e3" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_7d86fe80-0b7c-4d6e-924f-9238f8ee8845" xlink:to="loc_dei_EntityAddressStateOrProvince_3cdf37e6-608a-454e-9f09-81b919d778e3" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_35eba099-291f-4f29-b1d5-a61d43eda3b3" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_7d86fe80-0b7c-4d6e-924f-9238f8ee8845" xlink:to="loc_dei_EntityAddressPostalZipCode_35eba099-291f-4f29-b1d5-a61d43eda3b3" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_f7c9a7da-8e5a-4c64-8f8b-1501408ce655" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_7d86fe80-0b7c-4d6e-924f-9238f8ee8845" xlink:to="loc_dei_CityAreaCode_f7c9a7da-8e5a-4c64-8f8b-1501408ce655" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_2a7ff212-062b-4f48-8892-6e80ee879ca5" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_7d86fe80-0b7c-4d6e-924f-9238f8ee8845" xlink:to="loc_dei_LocalPhoneNumber_2a7ff212-062b-4f48-8892-6e80ee879ca5" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_0f7f1289-6039-4ee5-a379-08baaf2bf025" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_7d86fe80-0b7c-4d6e-924f-9238f8ee8845" xlink:to="loc_dei_WrittenCommunications_0f7f1289-6039-4ee5-a379-08baaf2bf025" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_011e88bb-f6b9-4da8-a149-a1d5c914fbd7" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_7d86fe80-0b7c-4d6e-924f-9238f8ee8845" xlink:to="loc_dei_SolicitingMaterial_011e88bb-f6b9-4da8-a149-a1d5c914fbd7" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_83c271ef-3839-49da-8064-69e18475b6d6" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_7d86fe80-0b7c-4d6e-924f-9238f8ee8845" xlink:to="loc_dei_PreCommencementTenderOffer_83c271ef-3839-49da-8064-69e18475b6d6" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_86172acc-d8d0-4812-8d1e-0eb3b00e7809" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_7d86fe80-0b7c-4d6e-924f-9238f8ee8845" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_86172acc-d8d0-4812-8d1e-0eb3b00e7809" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_6535ba49-992c-4276-a5bc-408d9282eb1a" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_7d86fe80-0b7c-4d6e-924f-9238f8ee8845" xlink:to="loc_dei_Security12bTitle_6535ba49-992c-4276-a5bc-408d9282eb1a" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_3d66c5fb-4ec6-421b-8b89-c3a20cd3b747" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_7d86fe80-0b7c-4d6e-924f-9238f8ee8845" xlink:to="loc_dei_TradingSymbol_3d66c5fb-4ec6-421b-8b89-c3a20cd3b747" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_fc5e162e-a500-4881-b6da-89ca55ec5244" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_7d86fe80-0b7c-4d6e-924f-9238f8ee8845" xlink:to="loc_dei_SecurityExchangeName_fc5e162e-a500-4881-b6da-89ca55ec5244" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_d039abe8-68a2-40d6-84ba-1005df1ad27c" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_7d86fe80-0b7c-4d6e-924f-9238f8ee8845" xlink:to="loc_dei_EntityEmergingGrowthCompany_d039abe8-68a2-40d6-84ba-1005df1ad27c" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_f97d9fcd-8e05-4321-9421-bbdaac018202" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_7d86fe80-0b7c-4d6e-924f-9238f8ee8845" xlink:to="loc_dei_EntityCentralIndexKey_f97d9fcd-8e05-4321-9421-bbdaac018202" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_59348ba9-cad8-4f9d-8e09-12fa4b1b8895" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_7d86fe80-0b7c-4d6e-924f-9238f8ee8845" xlink:to="loc_dei_AmendmentFlag_59348ba9-cad8-4f9d-8e09-12fa4b1b8895" xlink:type="arc" order="21"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>hum-20250326_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:b8d6c879-28c4-42c2-9fee-6c511a7e9ff9,g:db6499c3-a5bf-4115-99d2-37d705b81ee5-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_SecurityExchangeName_62d8c896-cb06-47dc-bb29-cc9e01d05c16_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_b31a0bf5-3b9f-40ab-8b74-b137b1645676_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_8196a02f-28e9-4ae0-837f-a18b25d2dab6_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_14e699bc-e6c1-49c8-8ef8-75ffc594ed11_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_c5fba1e6-646d-4fed-8f65-8a5bb6a68060_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_fd8d82f4-a8c7-42b5-bb54-5621424aa69c_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInformationLineItems_27d7843b-5f0c-4752-82bb-f1225f4f851e_terseLabel_en-US" xlink:label="lab_dei_EntityInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Information [Line Items]</link:label>
    <link:label id="lab_dei_EntityInformationLineItems_label_en-US" xlink:label="lab_dei_EntityInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInformationLineItems" xlink:to="lab_dei_EntityInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_261843eb-2470-4d0a-8c73-ad36b3daf980_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_dc3f2cec-b5f4-479a-881a-6952f175cc82_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_42870610-94f3-420a-988d-ebdb9a33e961_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_a0045dfa-e91a-4c95-b936-c41525ce533b_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_d28c4f57-bf57-40c7-a614-b1529bfeb833_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_20798ea3-442c-42ea-8ee0-bd83dd5158f7_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_aa3a6213-8de5-42f9-9883-c96d4075cfc6_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_42492c99-04f8-491b-bc7a-68128477c299_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_0f9e6503-4341-4d1d-9af3-2993355a6559_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_fdb61a6b-8426-4ca2-9a85-46e5b9515c1a_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_8dc63c42-bb9b-420b-a736-85b735bb735a_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_857c1780-5281-48ca-b1e9-153fbedd12be_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitiesTable_0148b9ef-1eb2-42aa-bba2-229b0590008a_terseLabel_en-US" xlink:label="lab_dei_EntitiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entities [Table]</link:label>
    <link:label id="lab_dei_EntitiesTable_label_en-US" xlink:label="lab_dei_EntitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitiesTable" xlink:to="lab_dei_EntitiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_7ff7192d-8f55-49f7-ad6f-6d3549e857a7_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_3b8f95ec-917f-4dc5-b62a-80cac5a7c28d_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_9d943509-aa57-46ae-9a9c-9a2989f2c133_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_57f69c3d-063f-49e4-9f27-503a4f52a96e_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>hum-20250326_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:b8d6c879-28c4-42c2-9fee-6c511a7e9ff9,g:db6499c3-a5bf-4115-99d2-37d705b81ee5-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.humana.com/role/DocumentandEntityInformationDocument" xlink:type="simple" xlink:href="hum-20250326.xsd#DocumentandEntityInformationDocument"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/DocumentandEntityInformationDocument" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_57ccbb48-054f-4a3c-9fbf-21d5b89325de" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable_6467a976-fc77-43a3-8693-a004d26257b1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_57ccbb48-054f-4a3c-9fbf-21d5b89325de" xlink:to="loc_dei_EntitiesTable_6467a976-fc77-43a3-8693-a004d26257b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems_7d86fe80-0b7c-4d6e-924f-9238f8ee8845" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInformationLineItems"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_6467a976-fc77-43a3-8693-a004d26257b1" xlink:to="loc_dei_EntityInformationLineItems_7d86fe80-0b7c-4d6e-924f-9238f8ee8845" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_641d440a-f1e0-4855-9162-2ef29f59d46f" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_7d86fe80-0b7c-4d6e-924f-9238f8ee8845" xlink:to="loc_dei_DocumentType_641d440a-f1e0-4855-9162-2ef29f59d46f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_099f3e2f-9d0d-4e2f-ac58-02e4f8398e77" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_7d86fe80-0b7c-4d6e-924f-9238f8ee8845" xlink:to="loc_dei_DocumentPeriodEndDate_099f3e2f-9d0d-4e2f-ac58-02e4f8398e77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_192a2493-9324-46c1-b9c1-724a8f22b8bd" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_7d86fe80-0b7c-4d6e-924f-9238f8ee8845" xlink:to="loc_dei_EntityRegistrantName_192a2493-9324-46c1-b9c1-724a8f22b8bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_c673e1fc-6773-43a3-925a-365e1cca5765" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_7d86fe80-0b7c-4d6e-924f-9238f8ee8845" xlink:to="loc_dei_EntityIncorporationStateCountryCode_c673e1fc-6773-43a3-925a-365e1cca5765" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_4fdbd8cb-a0b3-4aef-bdb6-20016835ac9b" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_7d86fe80-0b7c-4d6e-924f-9238f8ee8845" xlink:to="loc_dei_EntityFileNumber_4fdbd8cb-a0b3-4aef-bdb6-20016835ac9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_606fb398-063a-42bc-8b0b-a9ffb5d70dd7" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_7d86fe80-0b7c-4d6e-924f-9238f8ee8845" xlink:to="loc_dei_EntityTaxIdentificationNumber_606fb398-063a-42bc-8b0b-a9ffb5d70dd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_eeef2028-a88c-44e5-ab45-4490a2dbbdf5" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_7d86fe80-0b7c-4d6e-924f-9238f8ee8845" xlink:to="loc_dei_EntityAddressAddressLine1_eeef2028-a88c-44e5-ab45-4490a2dbbdf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_5e89ba77-ab04-4d06-82d2-e06f80448a9c" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_7d86fe80-0b7c-4d6e-924f-9238f8ee8845" xlink:to="loc_dei_EntityAddressCityOrTown_5e89ba77-ab04-4d06-82d2-e06f80448a9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_3cdf37e6-608a-454e-9f09-81b919d778e3" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_7d86fe80-0b7c-4d6e-924f-9238f8ee8845" xlink:to="loc_dei_EntityAddressStateOrProvince_3cdf37e6-608a-454e-9f09-81b919d778e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_35eba099-291f-4f29-b1d5-a61d43eda3b3" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_7d86fe80-0b7c-4d6e-924f-9238f8ee8845" xlink:to="loc_dei_EntityAddressPostalZipCode_35eba099-291f-4f29-b1d5-a61d43eda3b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_f7c9a7da-8e5a-4c64-8f8b-1501408ce655" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_7d86fe80-0b7c-4d6e-924f-9238f8ee8845" xlink:to="loc_dei_CityAreaCode_f7c9a7da-8e5a-4c64-8f8b-1501408ce655" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_2a7ff212-062b-4f48-8892-6e80ee879ca5" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_7d86fe80-0b7c-4d6e-924f-9238f8ee8845" xlink:to="loc_dei_LocalPhoneNumber_2a7ff212-062b-4f48-8892-6e80ee879ca5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_0f7f1289-6039-4ee5-a379-08baaf2bf025" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_7d86fe80-0b7c-4d6e-924f-9238f8ee8845" xlink:to="loc_dei_WrittenCommunications_0f7f1289-6039-4ee5-a379-08baaf2bf025" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_011e88bb-f6b9-4da8-a149-a1d5c914fbd7" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_7d86fe80-0b7c-4d6e-924f-9238f8ee8845" xlink:to="loc_dei_SolicitingMaterial_011e88bb-f6b9-4da8-a149-a1d5c914fbd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_83c271ef-3839-49da-8064-69e18475b6d6" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_7d86fe80-0b7c-4d6e-924f-9238f8ee8845" xlink:to="loc_dei_PreCommencementTenderOffer_83c271ef-3839-49da-8064-69e18475b6d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_86172acc-d8d0-4812-8d1e-0eb3b00e7809" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_7d86fe80-0b7c-4d6e-924f-9238f8ee8845" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_86172acc-d8d0-4812-8d1e-0eb3b00e7809" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_6535ba49-992c-4276-a5bc-408d9282eb1a" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_7d86fe80-0b7c-4d6e-924f-9238f8ee8845" xlink:to="loc_dei_Security12bTitle_6535ba49-992c-4276-a5bc-408d9282eb1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_3d66c5fb-4ec6-421b-8b89-c3a20cd3b747" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_7d86fe80-0b7c-4d6e-924f-9238f8ee8845" xlink:to="loc_dei_TradingSymbol_3d66c5fb-4ec6-421b-8b89-c3a20cd3b747" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_fc5e162e-a500-4881-b6da-89ca55ec5244" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_7d86fe80-0b7c-4d6e-924f-9238f8ee8845" xlink:to="loc_dei_SecurityExchangeName_fc5e162e-a500-4881-b6da-89ca55ec5244" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_d039abe8-68a2-40d6-84ba-1005df1ad27c" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_7d86fe80-0b7c-4d6e-924f-9238f8ee8845" xlink:to="loc_dei_EntityEmergingGrowthCompany_d039abe8-68a2-40d6-84ba-1005df1ad27c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_f97d9fcd-8e05-4321-9421-bbdaac018202" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_7d86fe80-0b7c-4d6e-924f-9238f8ee8845" xlink:to="loc_dei_EntityCentralIndexKey_f97d9fcd-8e05-4321-9421-bbdaac018202" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_59348ba9-cad8-4f9d-8e09-12fa4b1b8895" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_7d86fe80-0b7c-4d6e-924f-9238f8ee8845" xlink:to="loc_dei_AmendmentFlag_59348ba9-cad8-4f9d-8e09-12fa4b1b8895" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>fflogo.jpg
<TEXT>
begin 644 fflogo.jpg
M_]C_X  02D9)1@ ! 0( Q #$  #_X1LR17AI9@  24DJ  @    ' !(! P !
M     0   !H!!0 !    8@   !L!!0 !    :@   "@! P !     P   #$!
M @ -    <@   #(! @ 4    @    &F'!  !    E    *8   !A#P  %
M &$/   4    1TE-4" R+C$P+C(T   R,#(U.C S.C,P(# W.C,X.C,P  $
M : #  $    !          @   $$  $   #      0$$  $      0   @$#
M  ,    , 0   P$#  $    &    !@$#  $    &    %0$#  $    #
M 0($  $    2 0   @($  $    7&@        @ "  ( /_8_^  $$I&248
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M]6!A<H67:4=N,$<Y44 0?\*,^'__ $")?_ R7_XJC_A1GP__ .@1+_X&2_\
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M)UZ))9+2*-K:8@DK$2V5)'09R1GO@#TKP6TM+B_O(;2TA>:XF<1QQH,L[$X
M H ^\;"^M]3TZVO[.3S+6ZB6:%]I&Y& *G!Y'!'6O']8_P"3J/#_ /V#W_\
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M^6>X'; /W5/]X]1C (.1]*Z)H>F^'-*BTW2;2.UM(APB#J>Y)ZDGN3S6A10
M4444 %%%% 'P!1110 4444 %%%% !1110 4444 %%%% !114]G976HWD5I96
M\MS<RG;'%"A9F/H .30!!7H/P\^$VL>.72\?-EHP?#W3J=TH&<B(?Q'(P3T'
MN1BO2_AY\!8+(P:IXO5+BY'S+IH(:.,@@C>P.'Z?=^[ZYKW%$6-%1%"HH 55
M& !Z"@#"\*>#=$\&:8++1[-8R5433L,RSD=W;OU)QT&3@"M^BB@ HHHH ***
M* "BBB@#X HHHH **** "BBB@ HHHH **** "BE1&D=412S,<!0,DGTKW+X?
M? .XO3%J7C /;VW5=.1MLC\_\M&'W0>>!SSU% 'G/@CX=Z[X[O0FG0>78QR!
M+B]DXCBXS]6;'8>HS@'-?4/@3X;:'X"M,V49GU&6,1W%]*/GDYR0HZ(N>P]!
MDL0#746&GV6E6,5EI]I#:VL0(2&! B+DY. /4DGZFK- !1110 4444 %%%%
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M6B 'Z0 # !X #0 F  5A8W-P35-&5
M    ]M8  0    #3+6QC;7,
M                          UD97-C   !(    $!C<')T   !8    #9W
M='!T   !F    !1C:&%D   !K    "QR6%E:   !V    !1B6%E:   ![
M !1G6%E:   "     !1R5%)#   "%    "!G5%)#   "%    "!B5%)#   "
M%    "!C:')M   "-    "1D;6YD   "6    "1D;61D   "?    "1M;'5C
M          $    ,96Y54P   "0    < $< 20!- %  ( !B '4 :0!L '0
M+0!I &X ( !S %( 1P!";6QU8P         !    #&5N55,    :    ' !0
M '4 8@!L &D 8P @ $0 ;P!M &$ :0!N  !865H@        ]M8  0    #3
M+7-F,S(       $,0@  !=[___,E   'DP  _9#___NA___]H@   ]P  ,!N
M6%E:(        &^@   X]0   Y!865H@        ))\   ^$  "VQ%A96B
M      !BEP  MX<  !C9<&%R80       P    )F9@  \J<   U9   3T
M"EMC:')M       #     */7  !4?   3,T  )F:   F9P  #UQM;'5C
M      $    ,96Y54P    @    < $< 20!- %!M;'5C          $    ,
M96Y54P    @    < ', 4@!' $+_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P@ 1" 'T 7<# 1$  A$! Q$!_\0
M&@ !  ,! 0$               @)"@<&!?_$ !0! 0
M  #_V@ , P$  A #$    <_X
M                                          !Z L/('G@
M      2/)W@  \>58@  TNESY! QY       V^ RQ$(      "WXT_   C^8
M@P  7W&@XK0,F0      -_@,@1        M^-/P(   X^98@  ?0)OD,#SX
M/8'CP  >P/'@W^ R!$       "WXT_ P!@ %_P 7_$?S,$:33F!'\M_( &0(
M[>:3BQ\] 1 ,X)  $SS2\3//GE4!;>#($0       +?C3\#($ #SY8^7_'CP
M>P( $?RW\@ 9(C9X2@(WG(";X,<1Q\VFG0#GYQ\E  9 B       !;\:?@
M1_*@2_X'#RC$@@77%OY  J -/QR\RY'GRYXM?*L",!?<1_,:1S N>-+P,@1
M       M^-/P(_@ X@5X%_P,<1" &GTM_( $,"\X  $7R*!:>4H&;('T#?8#
M($0       +?C3\# &  7_%_QY\P1@&GTM_( %8!H^(WF9('7SSYR M?+OB
M!D"!-\V.@R!$       "WXT_ P!@ %_Q?\1_,08!I]+?R !F!-II[ I!(WE]
MQV S(D<#7Z"M B@6W'< 9 B       !;\:?@8 P "_XO^(_F(, T^EOY  R!
M%GQI^.@ %4!ER/GEYQH>/H X^=@!D"(       '7R4 (   '?R0!Y\A  2?.
MP'/R( /8$_SWY# C  #OY-\\@0/)@ A^>                      !I]!1
M"1@      +?C3\  "/YB#           -_@,@1        M^-/P  (_F(,
M         W^ R!$       "WXT_ P!@ %GQ9^<P*,"]\^>9T23Y?<2@./E8!
M.\&=$T7 JQ+CCN!!\SXG@#?X#($0 )WEQP*(2,    +?C3\# &  7_%_QQ\X
M@3/( &:$V6GL   8@C;Z  "N R1&_P !D"./FOT[ 9P2D$    M^-/P(_@ X
M@5X%_P  0@*T"9Y9^1/,J0-1Q,\&((V^@KP,^)<<7'@PA&[T&=$NN) %()G!
M    !;\:?@  1_*@2_X&;$I1!N<.P&7$J1!9>:S08@C;Z#($0 )'FVT&((V^
M@ J@,L0    !;\:?@8@@ ?/+CR_X&!,^>#;820,T)3""VXU' Q!&WT&((X =
M_-OH,01M]!R\Z@>/,>1$     %OQI^!@#  +_B_XC^8@P#3Z6_G'S."?/-'Q
MW &((V^@Q!' #OYM]!B"-OH,@1;<7'G'S&D<0    +?C3\# &  7_%_Q'\Q!
M@';S9:=@  !B"-OH,01P [^;?08@C;Z#($00-AI-\B^8TSQX   )?EGX* 0
M"?Y/\Y^4@@ Z^7GDOR+Y5B3_  4@%WX*0#P![\N_!2 7?@J . '7RY\$("N
M
M
M
M
M
M                                                     ';SB
M                   !;<:3C"&                     >_--Q:># &
M                  "P\T^G< # &                   #T!H>+O@ # &
M                   2_-1I+   & ,                  ^@7?&AX^@
M 8 P                 =_-/Q/\    P!@                %MQI..@
M   P!@               'OS3<6G@     P!@               L/-/IW
M     P!@              ] :'B[X       P!@             $OS4:2P
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MRTB14O5!VHBIUZ:1(E0)?ECT8S(H.@AKO#13\T,PIK(A)C45CD-:_P#=_\0
M%!$!                    L/_:  @! P$!/P$Y'__$ !01 0
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M)[A:%55&/1>%C95VMA7R9A40Q&GR.6C!V36^7U5/?W+)#:Z>R,VF*Z @+@%
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M_P" +3U%BOS'>C]R?YN\+*ZM#\6LIZ]RTL6=LQN.C7KD;;/LKC*P7:7$0FV
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M4G$TS 3Q?%T^+7J^TAC$UB1ZS>)&$6;2T9C ?*L&MN&X3H&$(1@22 K7JJ*
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M5M5@<3+LK,!E,1USBG H3"G(91RC.$M8ZZ:^,+',,AKZ-<O5QAL3F5Y[H,L
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M$]7BX63,5=7*'&=(2]F/97N+"#$95Y:N,GL<X\&M2DO(/@\N^S(^3+<+'%K
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M2JEHP1:M622T$J/[+!5TM;87%FUN<:NJTV+!YC9"1@VPHH,K!=I<13DVQRZ
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MIOTL6%@1=5<;%B\5AYK:A)E@L].K_?\ _\0 )1 !  $#! (" @,
M 0 0$5 @(4!!,#%A<6!PD-'Q_]H " $!  $_(?U!5PW<EM(K"2,X7'@H4TN
M:.\/\Z!"/>$4DS;,V,RUK4SY\^?/GJ"]@\S,0@&-9V%Y56/LV\^YU9MEEH&$
MSEJ)<LCAN_+:16%/EGM80%;ZWQIID3(I:0CCWIXU![G]]]]A8=^$[25A OD
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MH2 *$-R8$J!86L"(!?!A*#4U 8+"S&D?8(F;L"@ KY*_ZU/@'\<  X#6P]Y
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M&&0$6IB_>=*+N^1.46X?X;KZH-3^-]@KU+"7"#WA_G0(1[Q__]H # ,!  (
M P   !
M                           0              "2220  "        2
M      0  "                   "   0                   0    00
M0 2     0       "      " ""  2"0        0  " " 0"" 00"00
M   " 22   "    "00         0      0 " 2           "    " " 0
M 2"  "        0    0 0 2 "   0       "   "  "   2  2" 0
M                "2      "   0                   0  "
M           "   "00 2 222""0  "2    0    0 0   0     2     "
M22   ""2 "  0" "      0  " " 00  0 " 0 "     " 220  "" 0" 00
M" 0      0    0 022 0"" 0 02    "    " "0  " 00"   0
M   " 0 0"" 0""
M
M
M
M
M
M         "                      "0                     2
M                  "
M    0                                            0
M            2                     "0                      0
M                                           "
M                            "                      "0
M              2                      "
M                       0
M        0                      2               ?_\0 %!$!
M                L/_:  @! P$!/Q Y'__$ !01 0
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M(Q%SUQ2)A8 &*?$5)S + ![S=A\B+=+(4N^#P_25;<6*0QL>E:]5=_%(F%@
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M[-)I&05T2B[_ "E/"K2)TW,1X5E^=:RW'30@!;CI4QBI^(20!VZY$R2?DD0
MMQTJ8Q4_7O$?S?W_ /\ AQ,1G2>%%,+']Z54/,I%GVV.8E[AZND6?;8XB7N'
MDZF$8+;N1%:0GRN-'VB(19<"[(V-?);/G0D]E2HQ;Q5_LTFD9!71*+O\I3PJ
MTB=-S$>%9?G6LMQTT( 6XZ5,8J?B$D =NN1,DGY)$ +<=*F,5/U[Q'\W]_\
9_AQ,1G2>!?(O%TRL#VD6?;8YB7N'_=__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information Document<br></strong></div></th>
<th class="th"><div>Mar. 26, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 26,  2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Humana Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-05975<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">61-0647538<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">500 W. Main Street<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Louisville<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">KY<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">40202<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">502<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">580-1000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">HUM<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000049071<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>11
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( -" ?UI&QTU(E0   ,T    0    9&]C4')O<',O87!P+GAM
M;$W/30O", P&X+]2=K>9BAZD#D0]BIZ\SRYUA;8I;83Z[^T$/VYY><@;HBZ)
M(B:VF$7Q+N1M,S+'#4#6(_H^R\JABJ'D>ZXQW8&,L1H/I!\> \.B;=> A3$,
M.,SBM[#IU"Y&9W7/ED)WLCI1)L/B6#0ZL2<?J]P<"A#G>B4^BQ-+.9<K!?^+
M4\L54Y[FRF_\9 6_![H74$L#!!0    ( -" ?UH59)0P[@   "L"   1
M9&]C4')O<',O8V]R92YX;6S-DL%*Q# 0AE]%<F\G37 /H=N+XDE!<$'Q%I+9
MW6"3AF2DW;<WK;M=1!_ 8V;^?/,-3&NB,D/"YS1$3.0PWTR^#UF9N&5'HJ@
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MM5II ,,X?<D3$L/<@HL(2W@4R]9<X%L:+R/6ZK3;W5:$:6RA&$=D8'U>+&A
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M$4<P!L !0])T> \^>Q\ETWLJ.?]74_P$4$L#!!0    ( -" ?UJ7BKL<P
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M3AI_YHOA/UY_ 5!+ 0(4 Q0    ( -" ?UI&QTU(E0   ,T    0
M      "  0    !D;V-0<F]P<R]A<' N>&UL4$L! A0#%     @ T(!_6A5D
ME##N    *P(  !$              ( !PP   &1O8U!R;W!S+V-O<F4N>&UL
M4$L! A0#%     @ T(!_6IE<G",0!@  G"<  !,              ( !X $
M 'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4    " #0@']:N<KXGC $  "'
M$   &               @($A"   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL
M4$L! A0#%     @ T(!_6I^@&_"Q @  X@P   T              ( !APP
M 'AL+W-T>6QE<RYX;6Q02P$"% ,4    " #0@']:EXJ[',     3 @  "P
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52P4&      D "0 ^ @  YQ,

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="hum-20250326.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Document and Entity Information Document</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/DocumentandEntityInformationDocument</Role>
      <ShortName>Document and Entity Information Document</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" original="hum-20250326.htm">hum-20250326.htm</File>
    <File>hum-20250326.xsd</File>
    <File>hum-20250326_def.xml</File>
    <File>hum-20250326_lab.xml</File>
    <File>hum-20250326_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>17
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "hum-20250326.htm": {
   "nsprefix": "hum",
   "nsuri": "http://www.humana.com/20250326",
   "dts": {
    "inline": {
     "local": [
      "hum-20250326.htm"
     ]
    },
    "schema": {
     "local": [
      "hum-20250326.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "hum-20250326_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "hum-20250326_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "hum-20250326_pre.xml"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2023": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 25,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 22
   },
   "report": {
    "R1": {
     "role": "http://www.humana.com/role/DocumentandEntityInformationDocument",
     "longName": "0000001 - Document - Document and Entity Information Document",
     "shortName": "Document and Entity Information Document",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hum-20250326.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hum-20250326.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.humana.com/role/DocumentandEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.humana.com/role/DocumentandEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.humana.com/role/DocumentandEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://www.humana.com/role/DocumentandEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntitiesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntitiesTable",
     "presentation": [
      "http://www.humana.com/role/DocumentandEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entities [Table]",
        "label": "Entities [Table]",
        "documentation": "Container to assemble all relevant information about each entity associated with the document instance"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.humana.com/role/DocumentandEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.humana.com/role/DocumentandEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.humana.com/role/DocumentandEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.humana.com/role/DocumentandEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.humana.com/role/DocumentandEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.humana.com/role/DocumentandEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.humana.com/role/DocumentandEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.humana.com/role/DocumentandEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInformationLineItems",
     "presentation": [
      "http://www.humana.com/role/DocumentandEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Information [Line Items]",
        "label": "Entity Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.humana.com/role/DocumentandEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.humana.com/role/DocumentandEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.humana.com/role/DocumentandEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.humana.com/role/DocumentandEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Issuer Tender Offer",
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.humana.com/role/DocumentandEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Tender Offer",
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.humana.com/role/DocumentandEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.humana.com/role/DocumentandEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.humana.com/role/DocumentandEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Soliciting Material",
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.humana.com/role/DocumentandEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.humana.com/role/DocumentandEntityInformationDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Written Communications",
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>18
<FILENAME>0001628280-25-015646-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001628280-25-015646-xbrl.zip
M4$L#!!0    ( -" ?UJ<L^*\96D  $ZQ @ 1    97AH:6)I=#$Q+3AX:RYH
M=&WM?>EWVU:6Y_?Y*S!)58TT#:E$+98<5^<<6;839^+E6$JEZU,?$ !)Q"#
MQB*9]=?/W=Z&A8LDFQ*C/EVQ)!(/;[GO[O=W_S&IINF/_YC$0?3C__K'_][;
M\U[E83V-L\H+BSBHXLBKRR0;>[]'<?G9V]N3;UWDLWF1C">5=WAP>.+]GA>?
MD^N /Z^2*HU_5./\X^_\^S_^3B_YQS"/YC_^(TJNO23ZS^^29\'!<'1X_.QX
M]/SH^.#H>7 PB _.#IZ=CN*3.#H[^N_3T^_@6?@^/U16\S3^S^^F2;8WB7$"
M/YP>SJH7-TE437X8'!S\]3OG>U7\I=H+TF2<_4#3A4]'.2Q./@[S-"]^^/Z
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M!T>D;Q][.T4,$\69 B'A9''4TK,6_OI+ C<E&W^5<SW=/UOA8%\ J=.>_5#
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M)X\E][Y1ZA?]O35TAY^R>:IN7FC[N(9UPIGNP/]2Y8OF<ID51J?MI0?E"&4
M.GN?OVI*K.Q,(GI%*1U]:%5\<,I)'DAAJ E3F6V\E[US%[_"6O>][:TTK>[.
M/<*@*.8<8R1VKJ2";WQ0&A6>&P.7DDQYS26BW!(E*3_3^:,4CD!4H1-/V;,K
M%FNI*ZSO8^O+C:H7?ET(9P);"2)D1 XQ7#-^0^I<:/(2TW/K8M1?X1QKC*5L
ML]N^OCNA2#T2W-"2ZOW4*4M:GB 6.];Q#!&V,0; /R@]2D)NH!1$,8HK3$#D
MJAY/?J6/J%6I_3TW2.<^U/PLS&=SF1FN"EX+X@=684JL;D&=)&D)CR0H&>=[
M" I,?"TP&6N,IG/^=/*/;[^!.Y+ ,^PY0]CQ4(/)4:ZZQ_F [O-S=1EIW>B<
M0N>!CN :^'1.=U\G2+O-7/2Z]W)\,+&B %44=!&5Z?R.KF/E&Y=861J/.7?*
M\>&;+-52XV3?+;4C=SK/W3$O@T)DDC5,HX*\&('&AJY[,@>D*#J=-^VJ_G'Q
MUB(U\O4"=8/B[;#K\)+8]+Q;(9' ?:5VM>D. 10$5WJ%WF;J:V[Z G 2G0D,
M#YM)&9+?)M$'MZ, W[P%(!=/7K:O[V4[^SI>MH? N ;(N&[6#,:;&*0!N3.F
M?,-SW&%]K>K8R0L3UHF_3))A8FKK^GHN='HU."&MWZ_!D]="4[JA?LMY-[T>
ME<#^.%XSC&XA7ZPL']&?IYL'D>J7_L2!7&I 8/V39.9+I9]=Y^<SY(=)%T$9
M,LW%H[6*8)&4$:QVGU"X6IV^KE3T$?0&M"S\B:+16'A/O[&!@<Y6!=Z;T"^K
MBDOS=KIZ_/X>7#5#O/>:S:#<>!R++_,5W[.]Y#A?1(XZRZ*JBR$9P')G417(
MYW$;'D'(,R]6:$:$_O4IZDB9:$[>E+R_:ZDZVWLR_[Z[I2HP-(Q69^*O:)K:
M&9EQ1,5CE,O'*9F<HLO9H(HE^Y;+G_)IW)(U/-H)01Z$@13>V7X3Y5EHN$C[
MO&<K6V-;>_Q!L$2GT8546=X&*>ST=;KJ@6[AE8\<F]ZYL'11J3>:6 &2^\'@
M=TN,%#LGW8G.2TKAW"KLD8PPF'Z13Q/3<:T'3ZM?R*@B20?S, XG&1S<>"X>
MNRFFC8$,FY>@O6 FL ;IF 1%Q)A>93ZJ^"=,WN J^9E.MS4C-E)^,+]YG)O.
M5*[G0XM0W_!0WY*E%'< (Q?D\,*87+>GG%=NO"N[W@[0:\KOQCI1U8'\RKOD
MI=- KV!]!@KKAJB+[F3'.5DGA 0X"1BKDR@!*<@G7>4ZB6J*$G"F"(4.QV/8
M&.[AT^];:;*V%@UCZ0+R%\E12><K,#B&/RLT6]/1A#_J:#QEQQQS-+^_VPHY
MG##)$#$V0!^F<MZ6LZ*G\,MGES]%CG*8EG+<*H,$\3.L>F>72?HM/CLKDNL@
MY!W29P1S[#A7WW8#P,E5L89[8T#2]B.<95EG%@X& Z&&(:&XP>%3MCS,0N?(
M,P1G*,7.EI>-O7;9GG5$%N\@..?E!+.JMX-J3.C+%.-3?:B#\',]4[4"0<EQ
M='+;S^V+;&5Y<4(K"ZTY([@!7R@E.(,Y7>&6.LE)]@Q7:SF8E(W+U]^-JN-6
MNB5)>.*OA2."(5@)B"Z")@&_5.;PW#01/G6:"-M0M)QX:>4D9)+V4$[(%H;)
MS1 7MMFAR-M138@_O;T\5PR1J4L##93-5-RV3PV%J(S$N0*T7!*B/=WUZ(6,
M^IB'L-!"9:HU\H5DU!FF$&(3KS3(%H^(-[#M*#7<NI';G03#)(5=OL6:[?%U
MF]5,UL*ASYC_RAJ"U"741<\4) Y+,)\4@7_[3YP$K:LM&<G7JLI:?$:/KB91
M$=P@TC>P,W_9_JD*-<FH*;WCP>&3SW*3/LOG6Y49"/1U_/QT8!!*1!WXA'RA
MQKO#,?[!\[-G]\_8\$D%4P8O<GF;-B$77(^5&(FYO*9S<\5P7^S4,9BI;G=3
M[/ ;6/6D44P5K[GUP,)\XS6Y,Z:SC1UN:RI0L,@M5%H-_#(*DA2#6,B!0VIJ
M@IO "P^I[!/?QE4QHVYTU6U4$[AA:'_'T-<=D,&+M3B_)4+$ PVG+AX*G]T3
M",<0BK]"59-6P1?$>J^+K"?Q6S+V=:&!Z@'*EF\I@&[8/#GX$F.>H.2;XPF^
MSVE\%*^@N6,MIP$QN5.<3[OMV9#:P3(QDI/N5LCU:AKFS4G=7_21_7#XXMT_
M9R \ZN_I>.G6YW$[&_$JNP4(8VSVOE)GD4[29,O-8&]CU;6IW4(7.0^U2E9@
M^W+AA43E2I"8T([%\E+)L[!J/BU;3GDL5)':S(@A1%V$M^/S_"$"HT>E(*-;
MBJ M)=!^UD:O'>[@=N-C2H^UJE35D\IZMA'"A"_'Y/&4M\FV@&G/D0$TW]FS
M9"#)!>$\JP062S1MJRI:5-EE0[$&>;V+)88I5;Y@CA##1,X]LG#CC.J)\+XY
MY7[;?)/B_B:2[RW(Y15X)5,KGH2#;D&[>2<<"T6D-+8""!(@#5$S_+75#$JL
M8,>I:]8QDR8+1F4S(0#<C*F)6L<34@ F,HF:80",./E035(#4:"T<A "\&)A
M4IC""R"2CK&YL4%QL]VY#J#:[4"1C!-W*1Y+4O5AK? GO3@J>-9=R!P6/HH8
M<AVTXIZHVA4@%E^N-149.]X\= ;:,1!3:,QUQ,Z2!,BF(Y](\#*L&9)Z$R0"
M89@/I9W97*7G^1(F]U4A2TAZSPBC*1/RCJO-[DK$,= 5/(H+ITY\S/06&+5F
MK1NNZ 0^I[1;@: TC7!&02D5T(LTCQ! %*%8.K/;@:-LI;>-6T(N[@FY4J0/
MF2,UIL-O?8[C&7IK:T+N&^;Y9R6DL0ZS-*[2*9 =D9[V3EMU0>2;SE,E6@4
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MH5F9G#F2="/$XK0P\E;Q(0;<4@&(;1A/@G2T3O)Z8*,1[9+)C01"$A(?&H%
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M'HDZ^E%P35Y;>>XON5Z0TAY:GM#-J*I77;'M)!,<+KPY0S-IZ4,X3+C0@^S
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M&5,VK$75L_.,0VOBW&XI&3E?-@ )^)CU=:9"_55G(*9KDD#-6"H.5"1C:JK
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MW"_!W@JH:_*]\?%O=8\W3B/_L<FK,S"RYD%MBC><W1U,YU%<'9)U>'.4T?3
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MFT!9(K-<[?L?#B*=9XF<[^N4QJ=.!U-IQ\"+D2D*,]W?!F+.E2UT*!.W:F(
M/ZZ9U.DRHPH+?R(_LWO<H4=/B^CRLZU!9V]W;^7C;J>W\MF5P_8Z@][JQW<=
MMM?K;'57=VT.^Y0XP=P AN>93']>&ZSY#IF,(C""_7YV(7K XX96)2J^S'.3
M?6D]VUU0LZVE:O;RY/6+YX%X>7+T[M= O#HZ.7E]&HC35R>O_WAQ(GYZ,M@]
M$/\^.O[ME]/?WHDW;]Y7NNCX<\72N[CPM5LU;=IK2TUWVRSTAJFG8R&3XN>U
M.$[,V'0^96,8VX8+7_"(?MW=7G9Q%RL8[F07E6>I=> IF57U_26_TYJHUU^^
MD"_K8?HW$OU;:<.)&/0"<LA+G,SW(.I5"4-(\3H-._>$HNUN5WQ4>2'>2IV*
MT\(J55PB;;6TOY-PWYA2Y^<Z250@?H4]M0S/YF*K"Y+^ 6B7D8;19!J)?P'I
MB8*@X*<GV[L'MR"]:62?RKS0\9R_TFD$8^X/O]_R/BHA+?P)"XR29 Z.L4QS
ME8C"B(;Z!T**YRJ1,VP<&IL9*PMM4K%>3!1XYMU^OWMP;*;@4N?TJ7>P$0A0
MT="DJ0JIZ4P7$X'-3]18YX4;X+2 *(T"-OCPTMBI.-T<B/67&D**=Z8C!H/!
M9G\X' ZV-EJ3+1^DGKL$UEJ:[E2%I=4%2O$HA&EBT=L;# )<K(0^$<2(S8';
MS>L!B7RK\@R6@]S!+KAC( $R$3K/2YF&"L?_6W^[&X#<\ \R08['5HV!1)%9
MG88Z@_9R"HPF:K8[@^'VWX',5!L+:RY@YJA4X @'O19E1_5LS]6H:"S,4XG#
M80<GB8[X !]6=R/1CQ1*WL2QLL )U//<))$8S9LCT2I$5HX2'7);[)25%A=-
M[) ILWR&0Z,JP9)9KA&%X>S@^SOLX'%XG JX &V;$^&W_^Z\[XBWQHYAT :U
M;]X<T^-?8"B()'-Q+#-=P+*<AN8@G@PD!)."6IQ##\>.BC!E<Y&"T"/\VL+"
M6_S]O4G_D:>_XBU./0,G!AS#U:Z0/8YWI42+B2S:K(7>0-&U>O*W7M#4*U![
MYFEO0#S=@K68L<*%U::V6O:!:*Q\A3HYI<]+F&51=2;RG,1\ ZJWNS75,1P'
MS Q[@F?(R^F4#9@8I_-*M3KB(\X\-Z45F;)3X!$T QD#^R7P:YIA-W;+N3=^
MDK=5B299. $#G:CC*A53&2E:D"D+P3H=J4R1"X:?05\*/7;D6'&._A1",/X,
M_R,ETA8!ZX$2Z@)U#?3)")/IM/)P"RXB+T>?\",L%-0/1Y8A,%&&<Z266-M<
M$#P'-9WFM X\O68FO1Q\_)!;S36^J!:4,XB6=Q$Y&U.$O7@MI85P@IV+)-$?
ME6-8L=A&<^B"43@?,U+%#(==]#)(SR\R/<.NN,3_&'LF/E@<PC4+Q+O.44>L
MQ[ M*9O,Q5EJ9BG.=M.^L&=!:Y!R"*H"Y,-2EG7=(.]58'^E6C[I W]7.2$>
M+LLH#L&E.S_]808?YYLOD-\3<5JU(._HN-5B5MMWM+Q!U<'/^D 4\/6R< 2=
M#IMO@%9-6KBN-QH. 5A&9OIGB5^0D<8"0J$ VNF-GY[T=KH'Z@((3GE? 1O6
MP!29D#6'>)*+P90#G)PT"7Y4"5!A38J[J:5MRT0ETQ4".;QUL7/P^U".\11$
M/*7[$+D$%3M!JR JB_*% ( >Z0)59I3K2$M+GI\&=H2!A^/9ZLU=AQJ))]^*
M+0WM*>WY8.G ))A5P4;KVFE:'GO,V)HICX5[+E.X=&^^BE+ZDF:GQ0LED6Z9
M*S(7+ZT(^1,)D"O8F+1S\K$9<!2V(]R58L-Q(/B3S.1^YEKNL->@-V<!!BXD
M65@SVT>U>=WZ .!R"YN8;H%#_^[U=K(YV/ENAK(N-_SBOOWT;5[U^YTA\@'B
M#'4!FP5:(UC(W*O/JIAM>^\ARV=TG^33[5\EH,9F C(1*X7B9AB2-$Q.4<(^
M!$'D+5;FQYT,NW47.8+C"U!QJ<L7YM7P.E8-,-'\6ZKJ^.!](O^20?6Y_DD
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M8E+HKE%_B.:-94IU^WV*<RO51J7)?$:4]\]U5&6=:GH;F1[_%3L5NAO7O&Q
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M[#,$]DV%U,X=WSNP\RG_7J:G]/N@_@M02P,$%     @ T(!_6C_(:H\A%P
M^YP  !    !H=6TM,C R-3 S,C8N:'1M[3UK=^(XLM_G5^@RCT[.B8UMWB3-
MGC2=GF&F.\F&],[L?KE'V *\,;9',DFXO_Y62;:QP1!(YT$ZF0_3P9*EJE*]
M59*/_G$[\<@UX\(-_/?O3-UX1YAO!X[KC]Z_.^YW>[UW_^C\</0_FO;7AXO/
MY&-@3R?,CTB7,QHQA]RXT9A$8T;^#/B5>TW)N4>C8< GFJ9>ZP;AC+NC<40L
MPZHEW9)6WAXTG;K=;+0TJVE7M:IE6UIKR)A6MVNF21NL-1RV#D9M9U"OMEIV
M1:.UP5"KFF9-:[4<2ZLTG(91&S1-QFH'3KO6:E'3K#=K+:M>M1ML,*PR-FP9
MM&95[*IAR7G'$> ,>/NB?2O<]Z5Q%(7M<OGFYD:_J>@!'Y4MPS#+?WWYW+?'
M;$(UUQ<1]6U62MX:<"__'CY)WJR4E_I[KG]5-(_9:K7*LC7IZK#YP')0P6Q]
M%%R7H0$&MRI)QZ4A\R!@\X"*% 3W-BKN[?K0E>'BEB-.?8%K1R/@!IS-T(!D
MIA4/LAH#I&AF)@V SG5.D%@W&:RHT=0JYGR<5>B9E<Q LGO;H\"O)>9K7_NE
MSM&84:=S-&$1)3B"QOZ>NM?O2]W CX!WM<M9"'2QU:_WI8C=1F6)0;GSPP\_
M'$5NY+'.>#K1D&.-BE4_*JMG1V4U\B!P9ITCQ[TF(IIY['W)<47HT5G;#WP&
M\[NW;>S(N/K3=1SFRS^A_13DA[NVFOXVNF##]R5; ZQ].L&1F-L^\6&Z61>
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M^A&?=0,G;VHQ.8W9N(B%/+C&<>8VM@I^ ?/H#>4%&=!8;T3.ZZ3P)]=CT'D
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M<S1*G:H!8?.6P<XS)& V%*T86PQ]0@XT=T/J$7;+[&GD7F-$!#+&Q &AOD.
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M(4;Q29&Y%@73%08*,*D-D=/4:2T6YYX35Q2W\A-.0PX8 ()2T6S-4L_//\=
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MA=U[:_=]<+>YP.["7/9^ E!+ P04    " #0@']:B2K(ZD '  "K,@  %
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M.E];YOJA,)4^Z-N5' V!=_,72N*\OIX</)YH7]K_2CHY^"]02P$"% ,4
M" #0@']:G+/BO&5I  !.L0( $0              @ $     97AH:6)I=#$Q
M+3AX:RYH=&U02P$"% ,4    " #0@']: #N[I]83   6:@  $0
M    @ &4:0  97AH:6)I=#4Q+3AX:RYH=&U02P$"% ,4    " #0@']:/\AJ
MCR$7  #[G   $               @ &9?0  :'5M+3(P,C4P,S(V+FAT;5!+
M 0(4 Q0    ( -" ?UH.1ARX@ (  $X(   0              "  >B4  !H
M=6TM,C R-3 S,C8N>'-D4$L! A0#%     @ T(!_6HDJR.I !P  JS(  !0
M             ( !EI<  &AU;2TR,#(U,#,R-E]D968N>&UL4$L! A0#%
M  @ T(!_6OY[WM.A"@  ,5L  !0              ( !")\  &AU;2TR,#(U
M,#,R-E]L86(N>&UL4$L! A0#%     @ T(!_6D+ $D 9!P  938  !0
M         ( !VZD  &AU;2TR,#(U,#,R-E]P<F4N>&UL4$L%!@     '  <
*P $  ":Q      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>hum-20250326_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="hum-20250326.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
        </entity>
        <period>
            <startDate>2025-03-26</startDate>
            <endDate>2025-03-26</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-21">0000049071</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="c-1" id="f-22">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="c-1" id="f-1">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-2">2025-03-26</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="c-1" id="f-3">Humana Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-4">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="c-1" id="f-5">001-05975</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-6">61-0647538</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-7">500 W. Main Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-8">Louisville</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-9">KY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-10">40202</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-11">502</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-12">580-1000</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="c-1" id="f-13">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="c-1" id="f-14">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="c-1" id="f-15">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="c-1" id="f-16">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="c-1" id="f-17">Common Stock</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-18">HUM</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-19">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-20">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
